Sasayama’s Weblog


2009/08/30 Sunday

°Õ³°¤È½ÅÍפʹç°Õ¤Ø¤Î°ìΤÄͤˤʤꤽ¤¦¤Ê¡¢9·î¤ÎWTOÈó¸ø¼°³Õν²ñ¹ç

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 15:01:25

2009ǯ8·î30Æü
¡¡
null£×£Ô£Ï¤Î37¥«¹ñÈó¸ø¼°³Õν²ñ¹ç¤¬¡¢9·î3¡Ý4Æü¤Ë¡¢¥¤¥ó¥É¤Î¥Ë¥å¡¼¥Ç¥ê¡¼¤Ç³«¤«¤ì¤ë¤¬¡¢¤½¤ÎÃæ¿È¤Ê¤ê°ÕµÁ¤¬½ù¡¹¤ËÌÀ¤é¤«¤Ë¤Ê¤ê¤Ä¤Ä¤¢¤ë¡£

ÆüËܤϡ¢ÁíÁªµóľ¸å¤È¤¤¤¦¤³¤È¤Ç¡¢À¯¸¢¸òÂ夬¤¢¤ë¤Ë¤»¤è¡¢³Õν¤Î½ÐÀʤ¬º¤Æñ¤Ê¾ðÀª¤Î¤è¤¦¤Ç¤Ï¤¢¤ë¤¬¡¢°Õ³°¤Ë¡¢¡Öµ´¤Îµï¤Ì´Ö¡×¤Ë¡¢º£¸å¤ÎǯËö¤Ë¥¸¥å¥Í¡¼¥Ö¤Ç³«¤«¤ì¤ë¸ø¼°³Õν²ñ¹ç¤Ø¤Î¥í¡¼¥É¥Þ¥Ã¥×¤¬·è¤Þ¤Ã¤Æ¤·¤Þ¤¦¾õ¶·¤Î¤è¤¦¤À¡£

½ÅÍ×ÉÊÌܤòÊú¤¨¤ëÆüËܤȤ·¤Æ¤Ï¡¢¤½¤ì¤³¤½¡¢Çç¤Ã¤Æ¤Ç¤â½ÐÀʤ·¤Æ¤ª¤«¤Ê¤¤¤È¡¢¤¢¤È¤Ç¡¢¡Ö9·î¤Î¤È¤­¡¢²¿¤â¤¤¤ï¤Ê¤«¤Ã¤¿¤¸¤ã¤Ê¤¤¤Î¡×¤È°ì½³¤µ¤ì¤«¤Í¤Ê¤¤¾õ¶·¤Ê¤Î¤À¡£
(9·î1ÆüÉÕµ­-Æ󳬽ÓÇî·ÐºÑ»º¶ÈÁê¤âÀÐÇËÌÐÇÀÁê¤â¡¢½ÐÀʤ·¤Ê¤¤¤³¤È¤Ë¤Ê¤Ã¤¿¤è¤¦¤À¡£ÇÀÎӿ建¾Ê¤«¤é¤Ï»³ÅĽ¤Ï©ÇÀÎӿ建¿³µÄ´±¤¬½ÐÀʤȤ¤¤¦¤³¤È¤Ë¤Ê¤Ã¤¿¤è¤¦¤À¡££Ï£Å£Ã£Ä»²»ö´±¤Î·Ð¸³¤¬¤¢¤ë¤È¤Ï¤¤¤¨¡¢¤³¤Î7·î¤Ë¤«¤ï¤Ã¤¿¤Ð¤«¤ê¤Î¤«¤¿¤Ç¤¢¤ë¡£¤³¤ì¤Ç¤Ï¤¤¤±¤Þ¤»¤ó¤Í¡£¤Ê¤¼¡¢»ö̳¼¡´±¤Ç¤â¤¤¤«¤Ê¤«¤Ã¤¿¤Î¤«?¤³¤ì¤Ç¡¢¹ç°Õ¤Þ¤Ç¤Î¥í¡¼¥É¥Þ¥Ã¥×¤¬·è¤Þ¤ê¤«¤Í¤Ê¤¤¤ó¤Ç¤¹¤«¤é¡£·ÐºÑ»º¶È¾Ê¤«¤é¤Ï¡¢ÀÐÌÓÇî¹Ô·ÐºÑ»º¶È¿³µÄ´±¤¬½ÐÀʤȤΤ³¤È¤Ç¤¢¤ë¡£)

¤Ä¤Þ¤ê¡¢¥â¥À¥ê¥Æ¥£¤ÎÃʳ¬¤ò¥¹¥­¥Ã¥×¤·¤Æ¡¢²ÃÌÁ¹ñ¸Ä¡¹¤Î¥³¥ß¥Ã¥È¥á¥ó¥È¤òWTO¤ËÄ̹𤵤»¤ë¤È¤¤¤¦¡¢¿·¤·¤¤¹ç°Õ·ÁÀ®¤Î¤¿¤á¤Î¥¢¥×¥í¡¼¥Á¼êË¡¤¬¡¢¤³¤Î¥¤¥ó¥É¤Ç¤ÎÈó¸ø¼°²ñ¹ç¤Ç¼è¤é¤ì¤ë¸ø»»¤¬¶¯¤¯¤Ê¤Ã¤Æ¤¤¤ë¤«¤é¤À¡£

¤³¤ì¤Ï¡¢²ÃÌÁ³Æ¹ñ¤¬¡¢²¿¤Ë´Ø¿´¤ò»ý¤Ã¤Æ¤¤¤ë¤«¤òÌÀ¤é¤«¤Ë¤µ¤»¤ë¤¿¤á¤Î¡ÖÕ¶¶Ê¸ìË¡¡×(euphemism)¤Ç¤¢¤ë¤È¤¤¤ï¤ì¤Æ¤¤¤ë¡£

¤³¤Î¾õ¶·¤ÎÊѲ½¤Ë¤Ï¡¢Æó¤Ä¤Û¤É¤ÎÍ×°ø¤¬¤¢¤ë¤è¤¦¤À¡£

¤Ò¤È¤Ä¤Ï¡¢º£Ä«¤ÎÄ«Æü¿·Ê¹¤Ë¤â½ñ¤¤¤Æ¤¢¤ë¤è¤¦¤Ë¡¢º£²ó¤ÎÈó¸ø¼°²ñ¹ç³«ºÅÃϤΥ¤¥ó¥É¤¬¡¢Á°²ó¡¢2008ǯ7·î¤Ë¥¢¥á¥ê¥«¤ÈÂÐΩ¤·¤¹¤®¡¢¥É¡¼¥Ï¹ç°Õ¤ÎÃãÉñÂæ¤ò¤Ò¤Ã¤¯¤êÊÖ¤·¤Æ¤·¤Þ¤Ã¤¿¤³¤È¤Ø¤Î¡¢³«ºÅÃϤȤ·¤Æ¤ÎìÞºá°Õ¼±¤¬¤¢¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Î¤«¡¢¤È¤¤¤¦¤³¤È¡£
¤â¤¦¤Ò¤È¤Ä¤Ï¡¢¤³¤ì¤Ï¡¢¤ä¤ä¡¢¤¦¤¬¤Á²á¤®¤¿¸«Êý¤Ê¤Î¤À¤¬¡¢¸½ºß¡¢¥¤¥ó¥É¤¬¥ª¡¼¥¹¥È¥é¥ê¥¢¤È¤ÎFTAÄù·ë¤Ë»ê¤ëÁ°¤Î¥Õ¥£¡¼¥¸¥Ó¥ê¥Æ¥£¡¦¥¹¥¿¥Ç¥£¤ÎÃʳ¬¤ËÆþ¤Ã¤Æ¤ª¤ê¡¢¤½¤ÎÃæ¤Ç¡¢¥ª¡¼¥¹¥È¥é¥ê¥¢¤ÎÇÛθ¤Ç¡¢¥¤¥ó¥É¤¬WTO¤Î¾ì¤Ç¿À·Ð¼Á¤Ë¤Ê¤Ã¤Æ¤¤¤ë½ÅÍ×ÉÊÌÜ¡¦´Ø¿´ÉÊÌܤˤĤ¤¤Æ¡¢¥ª¡¼¥¹¥È¥é¥ê¥¢¤¬¡¢Îã³°ÉÊÌܤȤ·¤Æ¹üÈ´¤­¤ò¤·¤Æ¤¯¤ì¤Æ¤¤¤ë¤³¤È¤Ë¤Ä¤¤¤Æ¡¢µ¤¤ò¤è¤¯¤·¤Æ¤¤¤ë¡£¤È¤ÎÀ⤬¤¢¤ë¤è¤¦¤À¡£

¡Ö¥¤¥ó¥É¤Ï¡¢º£²ó¡¢¤É¤Á¤é¤Ë¤Ä¤¯¤«¤Î¥ê¥È¥Þ¥¹»î¸³»æ¤Ë¤µ¤é¤µ¤ì¤Æ¤¤¤ë¡×¤Ê¤É¤ÎÙèÙé¤â¤¢¤ë¤è¤¦¤À¡£

¤µ¤é¤Ë¡¢¥ª¡¼¥¹¥È¥é¥ê¥¢¤Ï¡¢¥¢¥á¥ê¥«¤¬¶²¤ì¤Æ¤¤¤ë¹ñÆâÇÀ»ºÊª²Á³Ê»Ù»ýÀ¯ºö¤ÎÁíÎ̵¬À©ÌäÂê(OTDS¡áOverall Trade-distorting Domestic Support¡¢ËÇ°×ÏĶÊŪ¹ñÆâ»Ù»ýÁ´Âζâ³Û)¤Ë¤Ä¤¤¤Æ¤â²ÉÌÛ¤ò´Ó¤¯¤³¤È¤Ç¡¢¥¢¥á¥ê¥«¤ËÊؾ褷¤¿¥Õ¥ê¡¼¥é¥¤¥É(¤¿¤À¾è¤ê)¤òÁÀ¤Ã¤Æ¤¤¤ë¤Î¤Ç¤Ï¤Ê¤¤¤Î¤«¡¢¤È¤Îµ¿¿´°Åµ´¤â¡¢Î®¤ì¤Æ¤¤¤ë¤è¤¦¤À¡£

¥±¥¢¥ó¥º¥°¥ë¡¼¥×ÆÃÍ­¤ÎéþéõŪ¤º¤ë¤µ¤¬¡¢°ä´¸¤Ê¤¯È¯´ø¤µ¤ì¤Æ¤¤¤ë¤è¤¦¤À¡£

¤Þ¤¢¡¢¸åÃʤÎÏäϡ¢¤Á¤ç¤Ã¤È¤¦¤¬¤Á¤¹¤®¤Æ¤¤¤ë¤È¤·¤Æ¤â¡¢100¥«¹ñ¤«¤é¤Ê¤ë¡Ö¥ì¥¤¥ó¥Ü¡¼Æ±ÌÁ¡× (rainbow coalition)(°Û¤Ê¤ë¥°¥ë¡¼¥×¤ÎÏ¢ÂÓ)¤ÎÃæ¿´¤¿¤ë¥¤¥ó¥É¤¬¡¢¤³¤ì¤Þ¤Ç¤È¤Ï¡¢Èó¾ï¤Ë°Û¤Ê¤ëÆ𲽤λÑÀª¤ò¼¨¤·¤Æ¤¤¤ë¤È¤³¤í¤«¤é¡¢¤Ë¤ï¤«¤Ë¡¢¥É¡¼¥Ï¥é¥¦¥ó¥É¤ÎǯÆâÂÅ·ë¡¢¤Þ¤¿¤Ï¡¢£²£°£±£°Ç¯¤Î½ÕÂŷ뤫¤Î¸«Ä̤·¤¬¶¯¤Þ¤Ã¤Æ¤­¤Æ¤¤¤ë¤È¤Î´¶¿¨¤ò¡¢´Ø·¸¼Ô¤Ï»ý¤Á¤Ä¤Ä¤¢¤ë¤è¤¦¤À¡£

¤½¤³¤Ç¡¢¤Ê¤¼¡¢º£²ó¤Î¥¤¥ó¥É¤Ç³«¤«¤ì¤ëÈó¸ø¼°³Õν²ñ¹ç¤¬½ÅÍפˤʤ뤫¤È¤¤¤¨¤Ð¡¢º£²ó¤Î²ñ¹ç¤Ë¤ª¤¤¤Æ¤Ï¡¢Ãæ¿È¤ÎÏäϤ»¤º¤Ë¡¢º£¸å¤ÎÂÅ·ë¤Ë»ê¤ë¥í¡¼¥É¥Þ¥Ã¥×¤ò³Îǧ¤·¤¢¤¦¤³¤È¤Î¤ß¤È¤Ê¤ê¤½¤¦¤Ê¤Î¤À¤¬¡¢¤½¤ÎÁ°Äó¤È¤·¤Æ¡¢»²²Ã³Æ¹ñ¤ËÂФ·¤Æ¡¢¤½¤Î¹ñ¤Ë¤È¤Ã¤Æ¤Î¥Õ¥¡¥¹¥È¡¦¥È¥é¥Ã¥¯(ºÇÍ¥Àè´Ø¿´²ÝÂê)¤È¤¹¤Ù¤­¡¢½ÅÍ×ÉÊÌܤ¬²¿¤Ç¤¢¤ê¡¢´Ø¿´»ö¤¬²¿¤Ç¤¢¤ë¤«¤ò¡¢ÌÀ¤é¤«¤Ë¤¹¤ë¤³¤È¤òÍ׵ᤷ¡¢¤½¤ì¤òÁ°Ä󡦸À¼Á¤Ë¤·¤Æ¡¢Ç¯Ëö¤Î¥¸¥å¥Í¡¼¥Ö²ñµÄ¤ËÎפࡢ¤È¤¤¤¦¹ç°Õ¤¬¤Ç¤­¤Ä¤Ä¤¢¤ë¤«¤é¤Ê¤Î¤À¡£

¤½¤Î°ÕÌ£¤Ç¡¢º£²ó¤Î²ñ¹ç¤Ï¡¢ºÆ¤Ó¡¢¿·¤¿¤ËÀ¸¤ß½Ð¤¹( re-invent)¤â¤Î¤Ï¡¢¤Ê¤Ë¤â¤Ê¤¯¡¢ºÆ¤Ó¡¢¹ç°Õ·ÁÀ®¤Ë¸þ¤±¤Æ¤ÎÆ°¤­¤ò³èÀ­²½¤µ¤»¤ë(re-energise )¤¿¤á¤Î¤â¤Î¤Ç¤¢¤ë¤È¡¢´Ø·¸¼Ô¤Ï¸À¤¦¡£

¤Þ¤¿¡¢º£²óÄ󼨤µ¤ì¤ë¤Ç¤¢¤í¤¦¹ç°Õ¤Þ¤Ç¤Î¥í¡¼¥É¥Þ¥Ã¥×¤Ï¡¢Íè·î9·î24¡Ý25Æü¤Ë¥¢¥á¥ê¥«¡¦¥Ô¥Ã¥Ä¥Ð¡¼¥°¤Ç³«¤«¤ì¤ëG20²ñµÄ¤Ø¸þ¤±¤¿¥á¥Ã¥»¡¼¥¸¤È¤â¤Ê¤ê¤¦¤ë¤â¤Î¤Ç¤¢¤ë¤È¤µ¤ì¤Æ¤¤¤ë¡£

¤â¤·¡¢ÆüËܤ«¤é¤Î³Õν¤¬¡¢¤³¤Î9·î¤ÎÈó¸ø¼°²ñ¹ç¤Ë½ÐÀʤ·¤Ê¤¤¤Ê¤é¤Ð¡¢½ÅÍ×ÉÊÌܤʤɤˤĤ¤¤Æ¤ÎÆüËܤȤ·¤Æ¤Î¥Õ¥¡¥¹¥È¡¦¥È¥é¥Ã¥¯(ºÇÍ¥Àè´Ø¿´²ÝÂê)Àë¸À¤¬¤Ç¤­¤Ê¤¤¤Ð¤«¤ê¤Ç¤Ï¤Ê¤¯¡¢Ç¯Ëö¤Î¸ø¼°³Õν²ñµÄ¤Ç¤ÎÆüËܤθºß´¶¤ò¡¢Ãø¤·¤¯Çö¤¤¤â¤Î¤È¤·¤Æ¤·¤Þ¤¦·üÇ°¤¹¤é¤¢¤ë¡£

»²¹Í

¤³¤ì¤Þ¤Ç¤Î¥É¡¼¥Ï¥é¥¦¥ó¥É¤Î·Ð°Þ

2001ǯ11·î¡¡
¥«¥¿¡¼¥ë¤Ç¤Î²ñ¹ç¡¢2005ǯ1·î¤ò¥´¡¼¥ë¤È¤¹¤ë¤³¤È¤Ç¹ç°Õ
2003ǯ3·î¡¡
ÇÀ»ºÊª´ØÀÇÌäÂê¡¢¹ñÆâ²Á³Ê»Ù»ýÌäÂꡢ͢½Ð¾©Îå¶âÌäÂê¤Ê¤É¤ÇÄùÀÚ´ü¸Â¤Þ¤Ç¤Ë¹ç°Õ¤Ë»ê¤é¤º¡£
2003ǯ9·î
ȯŸÅÓ¾å¹ñ¤ÇG20·ëÀ®
2004ǯ1·î
¥¢¥á¥ê¥«Ä̾¦ÂåɽÉô¤Î¤¼¡¼¥ê¥Ã¥¯»á¤¬¡¢¸ò¾ÄºÆ³«¤Ë¸þ¤±¤¿²ñ¹ç³«ºÅ¤òÄó°Æ
2004ǯ7·î
¥¸¥å¥Í¡¼¥Ö¤Ç¡¢¥é¥¦¥ó¥É·èÃå¤Î¤¿¤á¤Î¥Õ¥ì¡¼¥à¥ï¡¼¥¯¤Ë¤Ä¤¤¤Æ¡¢¹ç°Õ
2005ǯ1·î
¥é¥¦¥ó¥É·èÃ强ÇÔ
2005ǯ12·î
¹á¹Á¤Ç¡¢Âè¸Þ²ó³Õν²ñµÄ³«ºÅ¡£
2013ǯ¤Þ¤Ç¤ÎÇÀ»ºÊª´ØϢ͢½ÐÊä½õ¶â¤ÎűÇѤˤĤ¤¤Æ¡¢¹ç°Õ¤Ê¤ë¤â¤Î¤Î¡¢¹ñÆâÇÀ»ºÊª²Á³Ê»Ù»ý¡¦´ØÀÇűÇѤˤĤ¤¤Æ¤Î¹ç°Õ¤Ï¤Ê¤é¤º¡£
2006ǯ4·î
¹á¹Á²ñµÄ¤ÎÄùÀÚ´ü¸Â¤Ë¹ç°Õ¤¤¤¿¤é¤º¡£
2006ǯ7·î
G6¤Ç¤ÎÇÀ¶È´Ø·¸¹ç°Õ·èÎö¸å¡¢¸ò¾Ä°ì»þÃæÃÇ
2007ǯ2·î
WTO¤¬¡¢¸ò¾ÄºÆ³«¤òÀë¸À
2007ǯ4·î
¥Õ¥¡¥ë¥³¥Ê¡¼ÇÀ¶È¸ò¾ÄµÄĹ¥Ú¡¼¥Ñ¡¼2007ǯ5·î
WTO¤¬¡¢¥É¡¼¥Ï¥é¥¦¥ó¥É¤Î·èÎö¤Ï¡¢À¤³¦ËǰפÎȯŸ¤òÇ˲õ¤¹¤ë¤â¤Î¤Ç¤¢¤ë¤È·Ù¹ð
¥Õ¥¡¥ë¥³¥Ê¡¼ÇÀ¶È¸ò¾ÄµÄĹ¥Ú¡¼¥Ñ¡¼Â裲ÃÆ
2007ǯ6·î
¥¢¥á¥ê¥«¡¢EU¡¢¥Ö¥é¥¸¥ë¡¢¥¤¥ó¥É¤Î´Ø·¸³Õν¤¬¥Ý¥Ä¥À¥à¤Ç²ñ¹ç¡£
2007ǯ7·î
¥Õ¥¡¥ë¥³¥Ê¡¼ÇÀ¶È¸ò¾ÄµÄĹ¤Ê¤É¤«¤é¡¢¡ÖºÙÌܹç°Õ¡×Áð°Æ¡Ê¥â¥À¥ê¥Æ¥£¡¼¹ç°Õ°Æ)Äó¼¨
2008ǯ2·î
¥â¥À¥ê¥Æ¥£¤ÎÂè°ì¼¡²þÄûÈǥƥ­¥¹¥È¤¬Äó¼¨
2008ǯ5·î
¥â¥À¥ê¥Æ¥£¤ÎÂèÆ󼡲þÄûÈǥƥ­¥¹¥È¤¬Äó¼¨
2008ǯ7·î
¥â¥À¥ê¥Æ¥£¤ÎÂè»°¼¡²þÄûÈǥƥ­¥¹¥È¤¬Äó¼¨
¥ß¥Ë³Õν²ñµÄ¤Ç¡¢ÆÃÊÌ¥»¡¼¥Õ¥¬¡¼¥É(the Special Safeguard Mechanism¡áSSM) ¹ç°Õ·èÎö
¥¢¥á¥ê¥«¡¦¥¤¥ó¥É¤ÎÂÐΩ¤Ç¡¢¸ò¾Ä·èÎö
2008ǯ10·î
11·î¤Þ¤Ç¡¢Æ¤ÏÀ·Ñ³¤ò³Îǧ
2008ǯ11·î
WTO¤Ï¡¢12·î¤Þ¤Ç¤ËÇÀ¶ÈÌäÂê¡¢NAMAÌäÂê¤Î¥â¥À¥ê¥Æ¥£·èÃå¤Î¤¿¤á¤Î³Õν²ñµÄ¾¤½¸¤ò¶¯¤¯Í×ÀÁ
2008ǯ12·î
¥â¥À¥ê¥Æ¥£¤ÎÂè»Í¼¡²þÄûÈǥƥ­¥¹¥È¤¬Ä󼨡£
¤·¤«¤·¡¢¤³¤ì¤Ë¤Ä¤¤¤Æ¤ÎWTO¤Ç¤ÎµÄÏÀ¤Ï¤µ¤ì¤Ê¤«¤Ã¤¿¡£
WTO¤Ï¡¢´Ø·¸¹ñ¤ËÂФ·¤Æ¡¢2009ǯÁ᡹¤Ç¤Î²ñ¹ç¤òÍ×ÀÁ
2009ǯ4·î
¥í¥ó¥É¥ó¤Ç¡¢G20
2009ǯ6·î
¥¤¥ó¥É¥Í¥·¥¢¡¦¥Ð¥ê¤Ç¡¢¥±¥¢¥ó¥º¡¦¥°¥ë¡¼¥×²ñ¹ç
2009ǯ7·î
G8¥×¥é¥¹¤È¡¢APEC²ñ¹ç¤Ç¡¢2010ǯ¤Þ¤Ç¤Î¥É¡¼¥Ï¥é¥¦¥ó¥É·èÃå¤ò¹ç°Õ

»²¹Í
¡ÖIndia against change in Doha Round modalities at Delhi¡×
¡ÖÇÀ¶È¤Î¥â¥À¥ê¥Æ¥£¤Ë´Ø¤¹¤ëºÆ²þÄûµÄĹ¥Æ¥­¥¹¥ÈÅù¡×
¡ÖWho does not want to conclude the Doha Round?¡×

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

s

À襤ºÑ¤ó¤ÇÆü¤ÏÊë¤ì¤Æ—-

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 08:29:59

2009/08/30(Sun)
¡¡
null
Æâ³Õ´±Ë¼µ¡Ì©Èñ¤Ï¡¢¤¤¤Ä¡¢°ÜÆ°¤µ¤ì¤Æ¤«¤é¤Ã¤Ý¤Ë¤Ê¤ë¤ó¤À¤í¤¦¤«?
¤Ê¤ó¤ÆÉԶ࿵¤Ê¤³¤È¡¢¹Í¤¨¤Æ¤¤¤ë¤Î¤Ç¤¹¤¬—
º£ÈդäƤΤ⡢¤Ê¤ó¤À¤·–
¤¹¤Ç¤Ë¤Ã¤Æ¤Î¤â¡¢É餱¤ò³Ð¸ç¤·¤¿¤³¤È¤Ë¤Ê¤ë¤·–
¼óÈÉ»Ø̾¤¬¤¢¤ë¤Þ¤Ç¤Ï¡¢Â©¤¬¤¢¤ë¤ó¤À¤·¡¢¤½¤Î´Ö¤Ë¤¸¤ç¤¸¤ç¤Ë¡¢¤Ã¤Æ¤Î¤¬Áê¾ì¤Ê¤ó¤Ç¤·¤ç¤¦¤«¤Í—
¤Þ¤¢¡¢¤³¤Î¤¢¤¿¤ê¤Ï¡¢¤¹¤Ç¤ËµÜÂô¤µ¤ó¤«¤éºÙÀ¤ó¤ËÂå¤ï¤Ã¤¿¤È¤­¤ÎÁ°Îã¤Ê¤ê¥Î¥¦¥Ï¥¦?¤â¤¢¤ë¤ó¤À¤·¡¢º®Íð¤Ï¡¢¤Ê¤¤¤ó¤Ç¤·¤ç¤¦¤Í¡£

¼«Ì±Å޲ڤ䤫¤Ê¤ê¤·¤³¤í¤Ã¤Æ¤Î¤Ï¡¢µÄ°÷¤¬½¸ÃĤdz¤³°¤Ë¤¤¤¯¤Ã¤Æ¤È¤­¤Ï¡¢¤½¤ÎÃÄŤ¬¡¢¤½¤ì¤Ê¤ê¤Îñ´Ê̤ò´±Å¡¤«¤é³ÎÊݤ¹¤ë¤Î¤¬¡¢ÃÄŤÎÎÏÎ̤ò¼¨¤¹¥Ð¥í¥á¡¼¥¿¡¼¤ß¤¿¤¤¤Ê¤â¤Î¤¬¤¢¤Ã¤¿¤è¤¦¤Ç–
¤¤¤Ä¤À¤Ã¤¿¤«¡¢¤Ê¤¯¤Ê¤é¤ì¤¿º´¡¹ÌÚµÁÉ𤵤óÃÄŤλþ¤Ï¡¢¤³¤ÎÊýÀµÄ¾¤ÊÊý¤Ç¡¢º´¡¹ÌÚÀèÀ¸¤òÀèƬ¤ËÏ¢¤ìΩ¤Ã¤Æ¡¢½¸ÃĤǡ¢´±Å¡¤òˬ¤ì¤¿¤³¤È¤¬¤¢¤ê¤Þ¤·¤¿¤Ã¤±¡£
´±Ë¼Ä¹´±¤Î´ù¤Î±¦Âµ¤«¤é¡¢¤½¤ì¤Ê¤ê¤Î³ÊÉÕ¤±¤Î·³»ñ¶â¤¬¤ï¤¿¤µ¤ì¤Æ¤Þ¤·¤¿¤Ã¤±¡£
¤É¤¦¤â¡¢´ù¤Î¾å¤Î°ú¤­½Ð¤·¤ÎÊý¤È²¼¤Î°ú¤­½Ð¤·¤Î¤Û¤¦¤È¤Ç¤Ï¡¢ÂÞ¤ÎÃæ¿È¤Î¥í¥Ã¥È¤¬°Û¤Ê¤Ã¤Æ¤¤¤¿¤è¤¦¤Ç¤·¤¿¤Í¡£
º£¤È¤Ê¤Ã¤Æ¤Ï¡¢¤É¤¦¤Ç¤â¤¤¤¤¤³¤È¤Ç¤¹¤¬—

¤½¤ì¤Ë¤·¤Æ¤â¡¢Ìñ²ð¤Ê¤Î¤Ï¡¢³µ»»Í×µá¤ÎÁȤߤʤª¤·¡¢¤Ã¤Æ,¿û¤µ¤ó¡¢¸À¤Ã¤Æ¤¤¤ë¤è¤¦¤Ê¤ó¤Ç¤¹¤¬¡¢ÌÀÆü¤ÎÄù¤áÀÚ¤ê¤Ã¤Æ¤Î¤Ï¡¢º£¤ÎÁíÍý¤Î¸¢¸Â¤ÎÈÏáƤʤó¤Ç¡¢¤³¤ì¤ò¤É¤¦¤·¤è¤¦¤È¤¹¤ë¤ó¤Ç¤·¤ç¤¦¤«¤Í?
¤¤¤ï¤Ð¡¢ÌÀÆüÄù¤áÀÚ¤ê¤È¤Ê¤ë³µ»»Í×µá¤Ï¡¢»ÃÄê³µ»»Í×µá¤Ã¤Æ¤³¤È¤Ë¤Ê¤ë¤ó¤Ç¤·¤ç¤¦¤«¤Í¡£
ºâ̳¾Êͤ«¤ê¤Ã¤Æ¤Î¤¬¤Ç¤­¤ë¤â¤ó¤«¤É¤¦¤«—
ºÙÀîÀ¯¸¢¤Î»þ¤Ï¡¢¤½¤Î¤Þ¤Þ¡¢¤¤¤Ã¤Á¤ã¤Ã¤¿¤è¤¦¤Ç¤·¤¿¤Í¡£
¤Ç¡¢¤¢¤Î»þ¤Ï¡¢ËÜͽ»»À®Î©¤¬ÂçÉý¤ËÃÙ¤ì¤Æ¡¢Ä¹´ü¤Î»ÃÄê¤òÁȤó¤À¤è¤¦¤Ê–
Ã٤줿¤Î¤Ï¡¢¤Ò¤È¤¨¤Ë¡¢ºÙÀîÀ¯¸¢¤ÎÎÏÎÌÉÔ­¤Ã¤Æ¤È¤³¤À¤Ã¤¿¤ó¤Ç¤·¤ç¤¦¡£
À¯¼£²þ³×¤òÍ¥À褷¤¿¤¿¤á¡¢ËÜÍè¤ÏǯËö¤Ë½ª¤ï¤Ã¤Æ¤¤¤ë¤Ù¤­Ê¿À®6ǯÅÙͽ»»°Æ¤¬ÊÔÀ®¤µ¤ì¤¿¤Î¤Ï¡¢2·î15Æü¤Ç¤·¤¿¡£
¤½¤Î¸å¡¢ºÙÀ¤ó¤Î¥¹¥­¥ã¥ó¥À¥ë¤¬½Ð¤Æ¡¢Í½»»¿³µÄ¤¬¤Ç¤­¤Ê¤¯¤Æ¡¢4·î¤ËÂà¿Ø¤Ã¤Æ¤ªÁÆËö¤Ç¤·¤¿¤Í¡£
º£²ó¤â¡¢¤³¤ÎÄ´»Ò¤Ç¤¹¤È¡¢Ç¯Ëö¤Þ¤Ç¤Ëͽ»»ÊÔÀ®¤¬½ª¤ï¤ë¤Î¤Ï¡¢¤Á¤ç¤Ã¤ÈÆñ¤·¤¤¤è¤¦¤Ç¤¹¤Í¡£
¤Þ¤¢¡¢2·î15Æü¤È¤¤¤¦Á°Î㤬¤¢¤ë¤ó¤À¤«¤é¡¢¤³¤ì¤è¤êÃÙ¤ì¤Æ¤â¡¢¤Ã¤Æ²ÄǽÀ­¤â½Ð¤Æ¤­¤Þ¤¹¤Í¡£
¤Þ¤¢¡¢Ê̤˻ÃÄê¤òÁȤá¤ì¤Ð¤É¤¦¤Ã¤Æ¤³¤È¤Ï¤Ê¤¤¤ó¤Ç¤·¤ç¤¦¤¬¡£
¤½¤¦¤Ê¤ë¤È¡¢ÌÂÏǤò¤³¤¦¤à¤ë¤Î¤Ï¹ṉ̃¥µ¥¤¥É¤Ã¤Æ¤³¤È¤Ë¤Ê¤ê¤½¤¦¤Ç¤¹¤¬¡£
¤½¤¦¤¤¤¨¤Ð¡¢¤¢¤Î¤¢¤¿¤ê¤Ï¡¢ÆüËÜ¿·ÅÞ¤ÎÊý¡¹¤äµì¼Ò²ñÅޤʤɤÎÊý¡¹¤È¡¢Í¿ÅޤȤ·¤Æ¡¢°ì½ï¤ËÀ¯ºöºî¤ê¤Ê¤ó¤«¤·¤Æ¤¿¤ó¤Ç¤¹¤¬¡¢Ì¯¤ËÌò¿Í¤òÅÜÌĤ껶¤é¤¹¿·¿ÍµÄ°÷¤¬¤¤¤¿¤Î¤Ë¤Ï¡¢Êĸý¤·¤Þ¤·¤¿¤Í¡£
¤Þ¤³¤È¤Ë¡¢¡Ø±ï¤Ê¤­½°À¸¤ÏÅÙ¤·¤¬¤¿¤·¡Ù¤Ã¤Æ´¶¤¸¤Ç¤·¤¿¡£
º£²ó¤â¡¢Ì¯¤Êºø³Ð¤òµ¯¤³¤¹¿·¿ÍµÄ°÷¤¬·ë¹½¤¤¤ë¤ó¤Ç¤Ï¤Ê¤¤¤ó¤Ç¤·¤ç¤¦¤«¤Í¡£

À襤ºÑ¤ó¤ÇÆü¤ÏÊë¤ì¤Æ—-ÇÀÎӾʤÎÌò¿Í¤ò¤·¤Æ¤¤¤¿»ä¤Î¿ÆÉã¤Î²ó¸ÜÏäǤϡ¢½ªÀï¤ÎÁ°¸å¤¢¤¿¤ê¤«¤é¡¢²â¥ö´Ø°ìÂӤϡ¢½ñÎà¤ò¾Æ¤¯±ì¤Ç¡¢¤â¤¦¤â¤¦¤È¤·¤Æ¤¤¤¿¡¢¤Ã¤Æ¤¤¤Ã¤Æ¤Þ¤·¤¿¤±¤É¡¢¤¤¤Þ¤Ç¤¹¤È¡¢¥³¥ó¥Ô¥å¡¼¥¿¡¦¥Õ¥¡¥¤¥ë¤Î¥Ç¥£¥ì¡¼¥È¤Ã¤Æ¤È¤³¤Ç¤·¤ç¤¦¤«¤Í¡£
²»¤â¤Ê¤¯—8¥®¥¬¥Ð¥¤¥È¤¯¤é¤¤¤ÎUSB¥á¥â¥ê¡¼¤Ë°Ü¤·¤Æ¾Æü¤ò´ü¤¹¤Ã¤Æ¤È¤³¤í¤Ç¤·¤ç¤¦¤«¤Í¡£
¤â¤Ã¤È¤â¡¢¾ÃµîÉü³è¥½¥Õ¥È¤Ê¤ó¤Æ¤Î¤â¤¢¤ê¤Þ¤¹¤«¤é¤Í¡£
¤æ¤á¡¢¤´ÌýÃǤʤ¯¡£

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

2009/08/28 Friday

¸üÀ¸Ï«Æ¯¾Ê¤ÎH1N1ή¹Ô¥·¥Ê¥ê¥ª¤ÈCDC¤Î¡ÖFluView¡×¤È¤ÎÆþ±¡Î¨¤Î°ã¤¤¡¼³Ú´ÑŪ¤Ê¥·¥Ê¥ê¥ª¤«?

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 21:47:10

2009/08/28(Fri)
¡¡
º£Æü¡¢¸üÀ¸Ï«Æ¯¾Ê¤«¤éȯɽ¤µ¤ì¤¿º£¸å¤ÎÆüËܤˤª¤±¤ëH1N1¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹¤Îή¹Ô¥·¥Ê¥ê¥ª¤Ç¤Ï¡¢¼¡¤Î¤è¤¦¤ÊÍ¿·ï¤¬·Ç¤²¤é¤ì¤Æ¤¤¤ë¡£

¡Ê£±¡ËØí´µÎ¨(morbidity rates) ¡¡£²£°¡ó
¡Ê£²¡ËÆþ±¡Î¨(hospitalization rates) £±¡¥£µ¡ó¡¢
¡Ê£³¡Ë½Å¾É²½Î¨(severe /case-fatality rates) (CFR) £°¡¥£±£µ¡ó

¤³¤ì¤é¤Î¿ôÃͤò¡¢¥¢¥á¥ê¥«¤ÎCDC¤¬Ë轵ȯɽ¤·¤Æ¤¤¤ë¡ÖFluView¡×

¤ÈÈæ³Ó¤·¤Æ¤ß¤¿¤¤¤Î¤À¤¬

¤¿¤È¤¨¤Ð¡¢(2)¤ÎÆþ±¡Î¨¤òÈæ³Ó¤·¤Æ¤ß¤ë¤È¡¢¡ÖFluView¡×¤Ç¤Ï¡¢¼¡¤Î¤è¤¦¤Ë¤Ê¤ë¡£

2009ǯ4·î15Æü¤«¤é2009ǯ8·î15Æü¤Þ¤Ç¤ÎÎßÀÑÃÍ

­¡À¸¸å0¥ö·î¤«¤é23¥ö·î¤Þ¤Ç¡¡2.1 per 10,000
­¢2ºÐ¤«¤é4ºÐ¤Þ¤Ç 0.8¡¡ per 10,000
­£5ºÐ¤«¤é17ºÐ¤Þ¤Ç¡¡0.7 per 10,000
­¤18ºÐ¤«¤é49ºÐ¤Þ¤Ç0.4 per 10,000
­¥50ºÐ¤«¤é64ºÐ¤Þ¤Ç¡¡0.5per 10,000
­¦65ºÐ°Ê¾å¡¡0.5 per 10,000

¤È¤¤¤¦¤³¤È¤Ë¤Ê¤Ã¤Æ¤¤¤ë¡£

CDC¤Î¿ôÃͤǤϡ¢À¸¸å23¥ö·î¤Þ¤Ç¤ÎÆýÍÄ»ù¤ÎÆþ±¡Î¨¤Ï¹â¤¤¤¬¡¢À®¿Í¤ÎÆþ±¡Î¨¤Ï¡¢ÆüËܤΥ·¥Ê¥ê¥ª¤Û¤É¤Ç¤Ï¤Ê¤¤¡£

¤Á¤ç¤Ã¤È¡¢ÆüËܤÎÆþ±¡Î¨¤Î¿ôÃͤ¬¹â¤á¤Ë¤Ê¤Ã¤Æ¤¤¤ë¥·¥Ê¥ê¥ª¤Î¤è¤¦¤Ë¸«¤¨¤ë¤Î¤À¤¬¡£

¤Ê¤ª¡¢¤³¤Î¥µ¥¤¥È¡ÖPrevention of Influenza:Recommendations for Influenza¡¡Immunization of Children, 2007–2008¡×¤Î2¥Ú¡¼¥¸¡Ö1Estimated Influenza-Associated Hospitalization Rates, Selected Studies¡×¤Ë²áµî¤Î10Ëü¿Í¤¢¤¿¤ê¤ÎÆþ±¡Î¨¤Î°ìÍ÷ɽ¤¬¤¢¤ë¡£
0.5¥Ñ¡¼¥»¥ó¥ÈÆâ³°¤È¤¤¤Ã¤¿¿ôÃͤ¬°ìÈÌŪ¤Î¤è¤¦¤Ç¤¢¤ë¡£

¤Þ¤¿¡¢WTO¤Î2009ǯ7·î20Æü¤Î
¡ÖEpidemiology¡¡and Illness Severity of¡¡Pandemic (H1N1) 09 Virus¡×
¤Ç¤Î¡Ê£³¡Ë¤Î½Å¾É²½Î¨¤Ï¡¢0.2%¤È¡¢¸üÀ¸Ï«Æ¯¾Ê¤Î¥·¥Ê¥ê¥ª¤è¤ê¤Ï¡¢¤«¤Ê¤ê¹âÌܤοôÃͤȤʤäƤ¤¤ë¡£

¤Þ¤¿¡¢Â¾¤Î¿ôÃͤǤϡ¢0.4¥Ñ¡¼¥»¥ó¥È (0.3-1.5%) (WHO Rapid Pandemic Assessment Collaboration)¤«¤é1¥Ñ¡¼¥»¥ó¥È(61 deaths / 5728 cases )(WHO)¤È¤Î¿ôÃͤ⤢¤ë¡£
»²¹Í¡Ö2009 Influenza A(H1N1) – Human Swine Flu Is this the pandemic?¡×

(1)¤ÎØí´µÎ¨(morbidity rates) ¤Ë¤Ä¤¤¤Æ¤Ï¡¢1968ǯ¤«¤é1969ǯ¤Ë¤«¤±¤Æ¤Î¹á¹Á¥«¥¼H3N2¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Ç¤ÎØí´µÎ¨¤¬¡¢Â¿¤¯¤Î¥³¥ß¥å¥Ë¥Æ¥£¤Ç¤Ï¡¢50¥Ñ¡¼¥»¥ó¥È¤Ë㤷¤¿¤È¤³¤í¤«¤é¡¢¤³¤Î¸üÀ¸Ï«Æ¯¾Ê¤Î¿ôÃͤϡ¢¤ä¤äÄã¤á¤È¤ß¤é¤ì¤ë¡£

º£²ó¤Î¸üÀ¸Ï«Æ¯¾Ê¤Îή¹Ô¤Î¥·¥Ê¥ê¥ª¤Ç¤Ï¡¢Ä̾ï¤Î¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Î£²ÇÜÄøÅ٤ΡÖ20¡ó¡×¤òÀßÄꤷ¤Æ¤ª¤ê¡¢¡ÖÃÏ°è¤Ë¤è¤Ã¤Æ¤ÏºÇÂç30¡ó¤¬È¯¾É¤¹¤ë²ÄǽÀ­¤â¤¢¤ë¡×¤È¤Ï¤·¤Æ¤¤¤ë¤¬¡¢Èó¾ï¤Ë¹µ¤¨¤á¤Î¿ôÃͤȤϸ«¤¨¤ë¡£

Áí¤¸¤Æ¡¢Æþ±¡Î¨¤Ï¡¢CDC¤Î¼ÂÀÓ¤ËÈ椷¤Æ¤ä¤ä¹âÌܤȤϤ·¤Æ¤¤¤ë¤â¤Î¤Î¡¢¥·¥Ê¥ê¥ªÁ´ÂΤÎÁ°Äó¤È¤Ê¤ëØí´µÎ¨¤¬Èó¾ï¤ËÄã¤á¤Ç¤¢¤ê¡¢¤Þ¤¿¡¢½Å¾É²½Î¨¤âÄã¤á¤Ç¤¢¤ë¤È¤³¤í¤«¤é¡¢º£²ó¤Î¸üÀ¸Ï«Æ¯¾Ê¤Î¡Öή¹Ô¤Î¥·¥Ê¥ê¥ª¡×¤Ï¡¢¤ä¤ä¡¢³Ú´ÑŪ¤Ê¥·¥Ê¥ê¥ª¤Ç¤Ï¤Ê¤¤¤«¤È¿ä»¡¤µ¤ì¤¦¤ë¡£

null.

.

.

.

.

.

.

.

.

.

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

2009/08/27 Thursday

´Ú¹ñ¤¬¥¢¥á¥ê¥«¤È¤ÎFTAÄù·ë¤Ç¹Ô¤¦¹ñÆâÂкö¤Î³µÍ×

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 21:28:22

£²£°£°£¹Ç¯£¸·î£²£·Æü
¡¡
nullÆüËܤÎ̱¼çÅÞ¤¬¤¤¤È¤âµ¤·Ú¤Ë¡¢ÇÀ¶È¼Ô¸ÍÊ̽êÆÀÊä½þÀ©Å٤ȤΥȥ졼¥É¥ª¥Õ¤È¤·¤ÆÁªµó¸øÌó¤Ç¤¤¤¤¤À¤·¤Æ¤¤¤ë¡¢¥¢¥á¥ê¥«¤È¤ÎFTAÄù·ëÌäÂê¤À¤¬¡¢¤ªÎ٤δڹñ¤Ç¤Ï¡¢¹ñ²ñ¤Ç¤ÎÈã½Ú¤Ï¤Þ¤À¤Ç¤¢¤ë¤¬¡¢¤¹¤Ç¤Ë¡¢°Ê²¼¤Ë¸«¤ë¤è¤¦¤Ê·ì¤Î½Ð¤ë¤è¤¦¤Ê¹ñÆâÇÀÎӿ建¶ÈÂкö¤òÇ÷¤é¤ì¤Æ¤¤¤ë¡£

¤½¤Î³µÍפò°Ê²¼¤Ëµ­¤¹¤³¤È¤Ë¤¹¤ë¡£

¤Þ¤Å¡¢´Ú¹ñ¤Î¸½ºß¤ÎÇÀ¶È¤Î¼ÂÂ֤Ǥ¢¤ë¤¬¡¢1990ǯ¤Ë¤Ï°ìÀéËü¿Í¤¤¤¿ÇÀ²È¿Í¸ý¤Ï¡¢º£¤Ï¡¢»°É´¸Þ½½Ëü¿Í¤Ë¤Þ¤ÇÍî¤Á¹þ¤ó¤Ç¤¤¤ë¡£

ÅÁÅýŪ¤Ê´Ú¹ñ¤Îºîʪ¤Ï¡¢¥³¥á¡¢ÂçÇþ¡¢¾®Çþ¡¢¥³¡¼¥ó¡¢²Ì¼Â¡¢Ìʲ֤ʤɤǤ¢¤ë¡£

¥³¥áÇÀ²È¤Î·Ð±ÄÈ¿Ê̤ϡ¢3.5¥¨¡¼¥«¡¼ÄøÅ٤ǡ¢¥³¥áÇÀ²È¸Í¿ô¤Ï787,000¸Í¤Ç¡¢Á´ÂΤÎÇÀ²È¸Í¿ô¤Î57¥Ñ¡¼¥»¥ó¥È¤òÀê¤á¤Æ¤¤¤ë¡£

¥¢¥á¥ê¥«¤È¤ÎFTA¸ò¾Ä¤Ï£±£´¥ö·î¤ËµÚ¤ó¤À¤¬¡¢¥¢¥á¥ê¥«¡¢´Ú¹ñ¤È¤â¡¢¹ñ²ñ¤Ç¤ÎÈã½Ú·èµÄ¤Ï¤Þ¤À¤Ç¤¢¤ë¡£

¤È¤¯¤Ë¥¢¥á¥ê¥«¤Ï¥ª¥Ð¥Þ̱¼çÅÞÀ¯¸¢¤Ë¤Ê¤Ã¤Æ¤«¤é¡¢¥×¥í¥Æ¥¯¥·¥ç¥Ë¥º¥à¤¬µÄ²ñ¤Ë²£¹Ô¤·¡¢¥Ñ¥Ê¥Þ¡¢¥³¥í¥ó¥Ó¥¢¤Ê¤É¡¢Â¾¤Î¥Ú¥ó¥Ç¥£¥ó¥°¤È¤Ê¤Ã¤Æ¤¤¤ëFTAÈã½Ú¤È¤â¤Ë¡¢»ö¼Â¾åê¾å¤²¤È¤Ê¤Ã¤Æ¤¤¤ë¡£

°ìÊý´Ú¹ñ¤Ï¡¢EU¤È¤ÎÈã½Ú¤Ë¾è¤ê½Ð¤·¤¿¤ê¡¢¥¤¥ó¥É¤È¤ÎCEPA¤Ë¾è¤ê½Ð¤¹¤Ê¤É¡¢°ÕÍßŪ¤Ç¤¢¤ë¡£
»²¹Í¡Ö´Ú¹ñ¤È¥¤¥ó¥É¤È¤Î£Ã£Å£Ð£Á¤¬ËÜÆü½ð̾¡×

¤·¤«¤·¡¢¥ê¡¼¥Þ¥ó¥·¥ç¥Ã¥¯¸å¤Î¹ñÆâ»ö¾ð¤Ê¤ÉÍí¤ß¡¢¥¢¥á¥ê¥«¤È¤ÎFTAÈã½Ú¤Ë¤Ï¡¢´Ú¹ñÆâ¤Ë¤â¡¢¤³¤³¤ËÍè¤Æí´í°¤¹¤ë¤à¤­¤â¿¤¯¤Ê¤Ã¤Æ¤¤¤ë¤è¤¦¤À¡£

µíÆù¤È¼«Æ°¼Ö¤ÎÌäÂê¤â¡¢Î¾¹ñ¤Ë¤È¤Ã¤Æ²ò·è¤¹¤Ù¤­²ÝÂê¤È¤Ê¤Ã¤Æ¤¤¤ë¡£

º£·î¤Ï¤¸¤á¤Ë¤Ï¡¢ºÑ½£Åç¤Ç¤Î´Ú¹ñ»º¶ÈÏ¢¹ç¤Î¥Õ¥©¡¼¥é¥à¤Ë¥¢¥á¥ê¥«¤Î¥Ö¥Ã¥·¥åÁ°ÂçÅýÎΤ¬½ÐÀʤ¹¤ë¤Ê¤É¤·¤¿¤¬¡¢È¿±þ¤Ï¡¢Îä¤ä¤ä¤«¤Ê¤â¤Î¤È¤Ê¤Ã¤Æ¤¤¤ë¡£
»²¹Í¡Ö´Ú¹ñ¤ÎFTA»ö¾ð¡×

º£¸å¤ÎÊÆ´ÚFTA(KORUS FTA)Èã½Ú¤Î¸«Ä̤·¤À¤¬¡¢¥Ý¥¤¥ó¥È¤È¤Ê¤ë»þ´ü¤¬Æó¤Ä¤Û¤É¤¢¤Ã¤Æ¡¢¤Ò¤È¤Ä¤Ï¡¢º£Ç¯£±£±·î£±£´Æü¤Ë¥·¥ó¥¬¥Ý¡¼¥ë¤Ç³«¤«¤ì¤ëAPEC¤Î¥Õ¥©¡¼¥é¥à¤Ë¥ª¥Ð¥ÞÂçÅýÎΤ¬½ÐÀʤ¹¤ëÁ°¸å¤Ë¡¢´Ú¹ñ¤ËΩ¤Á´ó¤ê¡¢ÊÆ´Ú¼óǾ²ñÃ̤ÎÀʤǡ¢FTAÌäÂê¤ò´Þ¤à½ô²ÝÂê¤Ë¤Ä¤¤¤Æ¤ÎµÄÏÀ¤¬¤¢¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¡¢¤È¤¤¤¦¤³¤È¡¢¤â¤¦¤Ò¤È¤Ä¤Ï¡¢Íèǯ£´·î¤Ë¥½¥¦¥ë¤Ç³«¤«¤ì¤ë¤Ç¤¢¤í¤¦G20·ÐºÑ¥µ¥ß¥Ã¥È¤ÎÁ°¤Ë¡¢¥ª¥Ð¥ÞÂçÅýÎΤϡ¢Èã½Ú°Æ¤òÊƵIJñ¤ËÄó½Ð¤¹¤ë¤Î¤Ç¤Ï¤Ê¤¤¤«¡¢¤È¤¤¤¦´Ñ¬¤Ç¤¢¤ë¡£

¤·¤«¤·¡¢´Ú¹ñ¤ÎÇÀ¶È³¦¤Ç¤Ï¤¤¤Þ¤À¤Ë¡¢¥¢¥á¥ê¥«¤È¤ÎFTAÄù·ë¤Ëµ¿¿´°Åµ´¤ò»ý¤Ã¤Æ¤¤¤ë¤è¤¦¤À¡£

¤½¤ì¤Ï¡¢NAFTAÄù·ë¤Ç¤¹¤Ç¤Ë¸«¤Æ¤¤¤ë¥á¥­¥·¥³¤ä¥¢¥á¥ê¥«¤ÎÇÀ¶È³¦¤Î¾õ¶·¤¬¡¢¤«¤Ê¤é¤º¤·¤â¡¢¤Ð¤é¿§¤Î¤â¤Î¤Ç¤Ï¤Ê¤¤¤³¤È¤¬¤ï¤«¤Ã¤Æ¤¤¤ë¤«¤é¤À¡¢

¤¹¤Ê¤ï¤Á¡¢¥á¥­¥·¥³¤ÏNAFTA¤Î¸µ¤Ç¡¢150ËüÇÀ²È¤¬¹Ìºî¤òÃÇÇ°¤·¡¢¥¢¥á¥ê¥«¤Ë¤ª¤¤¤Æ¤â¡¢1997ǯ¤«¤é2002ǯ¤Î´Ö¤Ë¡¢9Ëü¤ÎÇÀ²È¡¢2000¥¨¡¼¥«¡¼¤ÎÇÀÃϤ¬¾Ã¤¨¤¿¤È¤¤¤¦»ö¼Â¤¬¤¢¤ë¡£

¤¤¤º¤ì¤â¡¢FTA Äù·ë¸å¡¢¥¢¥°¥ê¥Ó¥¸¥Í¥¹¤ÎÂæƬ¤ÈÂоÈŪ¤Ë¡¢¥Õ¥¡¥ß¥ê¡¼ÇÀ²È¤¬¾Ã¤¨¤¿¤È¤¤¤¦»ö¼Â¤¬»Ä¤Ã¤Æ¤¤¤ë¤«¤é¤À¡£

¤ª¤Þ¤±¤Ë¡¢¿©Êª²Á³Ê¤Ï27¥Ñ¡¼¥»¥ó¥È¾å¾º¤·¤¿¤Î¤ËÂФ·¤Æ¡¢1¥É¥ë¤¢¤¿¤ê¤ÎÇÀ¾ì·Ð±Ä¼Ô¤Ø¤Î»Ùʧ¤¤Ê¬¤Ï¡¢0.32¥É¥ë¤«¤é0.19¥É¥ë¤Ø¤ÈÄã²¼¤·¤¿¡£

¤Ä¤Þ¤ê¡¢¥Ð¥°¥ï¥Æ¥£¡ÊBhagwati¡Ë¤¬¤¤¤¦FTA¶¨Äê¤Î»ý¤Ä¡Ö¥¹¥Ñ¥²¥Æ¥£¥Ü¡¼¥ë¸½¾Ý¡×(Spaghetti Bowl Phenomenon)¤¬¡¢·ë²ÌŪ¤Ë¤Ï¡¢¹ñºÝŪ¤ËÆ°¤­²ó¤ê¤¦¤ë¥¢¥°¥ê¡¦¥Ó¥¸¥Í¥¹¤Î¤ß¤òÂÀ¤é¤¹¤È¤¤¤¦¤³¤È¤Ê¤Î¤À¤í¤¦¡£
»²¹Í¡Ö¼«Í³Ëǰ׶¨Äê¡ÊFTA¡Ë¤Ï¡¤¤à¤·¤í¼«Í³ËǰפòÁ˳²¤¹¤ë¡©¡½¡½¸¶»ºÃϵ¬Â§ËÇ°×À©¸ÂÅ٤η×ÎÌʬÀÏ¡½¡½¡×
¡ÖSpaghetti Bowl Phenomenon and Crucification of Multilateralism: Task Ahead for WTO ¡×

(Ãí¡Ý¤³¤³¤Ç¤Î¥¹¥Ñ¥²¥Ã¥Æ¥£¥Ü¥¦¥ë¸½¾Ý¤È¤Ï¡¢
¡ÖFTA¤Ë¤è¤Ã¤Æ¡¢ÆÃÄê¹ñ¤Î»ºÉʤÀ¤±´ØÀǤ¬·Ú¸º¡¦Å±ÇѤµ¤ì¡¢¤Þ¤¿¡¢¤½¤Î´ØÀǤ¬·Ú¸º¡¦Å±ÇѤµ¤ì¤ëÉÊÌܤòÆÃÄꤹ¤ë¤¿¤á¤Ë¤Ï¸¶»ºÃϵ¬Â§¤ò¸µ¤Ë¤¹¤ë¤³¤È¤Ë¤Ê¤ë¤¿¤á¡¢µ¬À©¤ÎºøÁÀ¸¤¸¡¢¸¶»ºÃϵ¬Â§¤¬¡¢¤«¤¨¤Ã¤Æ¡¢À¸»º¡¦Ä´Ã£¤ÎÀ©ÌóÍ×°ø¤È¤Ê¤ê¡¢¤½¤Î·ë²Ì¡¢ºÇŬ¤ÊÀ¸»º¥Í¥Ã¥È¥ï¡¼¥¯¤¬·ÁÀ®¤µ¤ì¤¨¤Ê¤¤¡£¡×
¤È¤¤¤¦¤³¤È¤ò¤¤¤Ã¤Æ¤¤¤ë¡£
¸¶»ºÃϵ¬Â§¤ÎÅý¹ç¤¬Æñ¤·¤¤¤¿¤á¡¢³Æ¶¨Äꤴ¤È¤Ë¡¢¥í¡¼¥«¥ë¥ë¡¼¥ë¤Î¤ß¡¢Áý¤¨¤Æ¤¯¤ë¡£
¤³¤ÎÊ£»¨¤«¤ÄµðÂ礫¤ÄºøÁ¤¿²óÏ©¤òÆ°¤­²ó¤ì¤ë¤Î¤Ï¡¢Ãæ¾®´ë¶È¤Ç¤ÏÆñ¤·¤¯¡¢ÆÃÄê¤Î¿Íͤʥͥåȥ¥¯»ñ¸»¤ò»ý¤Ä¡¢µðÂç¤Ê¥¢¥°¥ê¡¦¥Ó¥¸¥Í¥¹¤Ë¤Î¤ß¸Â¤é¤ì¤Æ¤·¤Þ¤¦¡£
¤È¤¤¤¦¤³¤È¤Ê¤Î¤À¤í¤¦¡£)

FTA¤Ëȼ¤Ã¤Æ¤Î´Ú¹ñ¤ÎÇÀ¶È¤Ï¡¢¥³¥á¤ÏFTA¤Ç¤ÏÎã³°ÉÊÌܤȤʤäƤ¤¤ë¤¬¡¢2014ǯ¤Þ¤Ç¤Ë¤Ï¡¢´Ú¹ñ¤ÎÊƻԾì¤Ï³«Êü¤µ¤ì¤ë¤Ç¤¢¤í¤¦¤È¤µ¤ì¤Æ¤¤¤ë¡£

ÇÀ»ºÊª´ØÀǤˤĤ¤¤Æ¤Ï¡¢º£¸å¿ôǯ¤Ë¤ï¤¿¤Ã¤Æ½ù¡¹¤Ë²¼¤²¤ë¤³¤È¤Ë¤È¤Ë¹ç°Õ¤·¤Æ¤¤¤ë¡£

µíÆù¤ÎÍ¢ÆþÀǤϡ¢14ǯ¤ÇűÇѤ·¡¢ÆÚÆù´ØÀǤÏ2014ǯ¤ËűÇÑ(Lift)¡¢Â¾¤Î´ØÀǤˤĤ¤¤Æ¤â¡¢2ǯ¤«¤é20ǯ°ÊÆâ¤ËűÇѤȤʤ롣

¤Þ¤¿¡¢¤ê¤ó¤´¤äÀ¾ÍÎÍü¤Ê¤É¤Î¥»¥ó¥·¥Æ¥£¥ÖÉÊÌܤˤĤ¤¤Æ¤Ï¡¢Ê̤ËÂкö¤¬ºÎ¤é¤ì¤ë¤³¤È¤È¤Ê¤Ã¤Æ¤¤¤ë¡£

¤³¤Î¤è¤¦¤ÊÁ°Äó¤òƧ¤Þ¤¨¤Æ¡¢âº ÉðîëÁ°ÂçÅýÎΤÏ1190²¯¥É¥ë¤ÎÇÀ²È±ç½õ¤òÌ󫤷¤¿¤Û¤«¡¢²¼µ­¤Î¤è¤¦¤ÊFTA¹ñÆâÇÀ¶È¼ÔÂкö¤¬ÁȤޤì¤Æ¤¤¤ë¡£

­¡20Ãû¥¦¥©¥ó-10ǯ´Ö¤ÎÇÀ¶È¶¦Æ±»ñ¶â¤ÎÍ»»ñ¡¢2008ǯ¤«¤é¥¹¥¿¡¼¥È¡¢´Ú¹ñ¤ÎÇÀ¶ÈÂμÁ¶¯²½¤òÌܻؤ¹¡¡¥í¡¼¥«¥ë¤ÊÇÀ»ºÊª¤Î¿¶¶½¤òÌܻؤ¹

­¢FTA´ØϢͻ»ñ¡¡12.1Ãû¥¦¥©¥ó¡¡¡¡¤¹¤Ç¤Ë¤¢¤ë2004ǯ-2013ǯ¤Ë¤ï¤¿¤Ã¤Æ¤ÎÇÀ¶È¡¦ÇÀ¼»Ù±ç·×²è¤Î119Ãû¥¦¥©¥ó¤Î¤Ê¤«¤«¤é¥Õ¥¡¡¼¥à¥í¡¼¥ó¤Ê¤É¤¬³ä¤êÅö¤Æ¤é¤ì¤ë¡£

¤³¤ì¤é¤Î¥í¡¼¥ó¤Ï¼¡¤Ëʬ¤±¤é¤ì¤ë¡£
7Ãû¥¦¥©¥ó-·ÐÈñ
2Ãû¥¦¥©¥ó¡Ý¸½ºß¤¢¤ë¥×¥í¥°¥é¥à¤ÎÊ䶯
3.1Ãû¥¦¥©¥ó–ÉÔÎɺĸ¢½þµÑ(business write off)
ÄɲÃ8.3Ãû¥¦¥©¥ó¡¡»Ù»ýºö¤¬2014ǯ¤«¤é2017ǯ¤Þ¤ÇÊݾ㤵¤ì¤ë¤è¤¦¤Ë20.4Ãû±ß¤Þ¤Ç»Ù»ýºö¤ò³ÈÂç

­¤Êä½õ¶â
û´ü¥À¥á¡¼¥¸Âкö-12²¯ÆóÀ饦¥©¥ó
¥¢¥°¥ê¥Ó¥¸¥Í¥¹¤ÎºÆÊÔ-12Ãû1459²¯¥¦¥©¥ó
ÇÀ¶ÈÉÊÌܤζ¥ÁèÎϳÈÂç-6Ãû9968²¯¥¦¥©¥ó

­¥ÇÀ¶È¤Î¥À¥á¡¼¥¸Êä½þ-FTA¹ç°Õ¸å7ǯ´Ö¡¡¡¡¤Ö¤É¤¦¡¢¥­¥¦¥¤¤Ê¤É

¥¢¥á¥ê¥«¤«¤é¤ÎÇÀ»ºÊªÍ¢Æþ¤¬Áý¤¨¡¢´Ú¹ñ¹ñÆâ¤ÎÀ¸»º¤¬Ç¯»º¥Ù¡¼¥¹¤ÇÈ¿Ê̤ǡ¢80¥Ñ¡¼¥»¥ó¥È¥«¥Ã¥È¤µ¤ì¤¿¾ì¹ç¤Ë¤Ï¡¢¤³¤ì¤Ë¤è¤Ã¤Æ¼º¤Ã¤¿¼ýÆþ¤Î85¥Ñ¡¼¥»¥ó¥È¤ò¥­¥ã¥Ã¥·¥å¤ÇÆÀ¤ë¤³¤È¤¬¤Ç¤­¤ë¡£

­¦¥í¡¼¥«¥ë¤ÊÇÀ»ºÊª¤Ë¤Ä¤¤¤Æ¤Ï¡¢¶¥ÁèÎϳÈÂç¤Î¤¿¤á¤ÎÀïάÉôÌç¤òÀ¯Éܤ¬ÃÖ¤¯¡£
Ʊ»þ¤Ë¡¢¥í¡¼¥«¥ë¤ÊÇÀ»ºÊª¤ÎÉʼÁ¸þ¾å¤È¡¢´Ä¶­¤Ë¤ä¤µ¤·¤¤Í­µ¡ÇÀ»ºÊª¤Ç¤â¤Ã¤Æ¡¢Äã²Á³Ê¤ÎÍ¢Æþʪ¤ËÂй³¤¹¤ë
¤ß¤«¤ó¤Ë¤Ä¤¤¤Æ¤Ï¡¢7ǯ°ÊÆâ¤Ë¡¢¥ª¥ì¥ó¥¸¤Ë²Ý¤»¤é¤ì¤Æ¤¤¤ëµ¨Àá´ØÀǤò¥¼¥í¤Ë¤¹¤ë¡£
¥ª¥ì¥ó¥¸¤Î¥¢¥á¥ê¥«¤«¤é¤ÎÍ¢Æþ¤Ï¡¢½ü¤¸¤ç¤ËÁý¤¨¤Æ¤¯¤ë¤â¤Î¤È»×¤ï¤ì¡¢ºÑ½£Åç¤Ç¤Î¥ª¥ì¥ó¥¸À¸»º¤Ê¤É¤Ï¡¢½Ì¾®¤·¤Æ¤¤¤¯¤â¤Î¤È»×¤ï¤ì¤ë¡£

²ÈÃܤˤĤ¤¤Æ¤âÉʼÁ¸þ¾å¤òÌܻؤ¹

­§ÇÀ¶È¤ÎºÆÊÔÀ®¡¢
Ϸǯ¼Ô¤Î¥ê¥¿¥¤¥¢Â¥¿Ê-ÅÚÃϤÎÊä½þ¤ò¤¹¤ë¡£¡¡
¼ãǯ¼Ô¤Îµ¢ÇÀ¤Ø¤Î¥¤¥ó¥»¥ó¥Æ¥£¥Ö¤ò¤â¤¦¤±¤ë

­¨ÇÀ¶È¥¯¥é¥¹¥¿¡¼¸¦µæ¥»¥ó¥¿¡¼¤Î³È½¼

­©Ä¾ÀÜ»Ùʧ¤¤¤Î³È½¼
FTA¤Ëȼ¤¦Â»¼º¤Î³ÈÂç¤ËÂбþ¤·¤¿Ä¾ÀÜ»Ùʧ¤¤¤Î³ÈÂç¤ËÂбþ¤·¤Æ¡¢ÆÃÊÌË¡¤Î½¤Àµ¤ò¹Ô¤¦¡£

¤Ê¤ª¡¢£²£°£°£´Ç¯¤ËÀ®Î©¤·¤¿ÆÃÊÌË¡¤Ë¤Ï¡¢¼¡¤Î¤â¤Î¤¬¤¢¤ë¡£¡£
­¡ÇÀµù¼»Ù±çÆÃÊÌË¡¡Ê£±Ãû£²À鲯¥¦¥©¥ó¤ÎÆÃÊÌ´ð¶â¤Ë¤è¤ëµßºÑ¡Ë
­¢ÇÀµù¼ÆÃÊÌÀDZäĹÆÃÊÌË¡¡ÊƱÀǤλþ¸Â±äĹ¡Ë
­£ÇÀ²ÈÉéºÄ·Ú¸ºÆÃÊÌË¡¡ÊÀ¯ºö¶âÍø°ú²¼¤²¤ÈÉéºÄÀ°Íý»ñ¶âÁÏÀßÅù¡Ë
­¤ÇÀµù¼À¸³è¤Î¼Á¸þ¾å¤ª¤è¤ÓÇÀµù¼Ãϰ賫ȯ¥¿ÊÆÃÊÌË¡¡Ê·ò¹¯¡¦¶µ°é¡¦Ê¡»ãÂкö¡Ë

¸½ºß¤Î¥­¥¦¥¤¡¡²¹¼¼¤Ö¤É¤¦¡¡¤«¤é¡¡µíÆùÆÚÆù¡¢¥Þ¥ó¥À¥ê¥ó¤ß¤«¤ó¡¡Æ¦¤Ø¤Î³ÈÂç
Êä½õ¶â¤Ë¤Ä¤¤¤Æ¤â¸½ºß¤Î¥­¥¦¥¤¡¡²¹¼¼¤Ö¤É¤¦¡¡¤â¤â¡¡¤«¤é¾¤ÎÉÊÌܤ˳ÈÂç

­ª£±¡¥£²Ãû¥¦¥©¥ó¤ÎËÇ°×Ä´À°±ç½õ´ð¶â¤ÎÁÏÀß

­«¤½¤Î¾
ÃÜ»º±à·ÝºîʪÎÓ»º¹òʪ¤Ê¤È¤Î¶¥ÁèÎϤò¹â¤á¤ë¤¿¤á¤ÎÀ¸»ºÀßÈ÷¤Î¶áÂå²½¡¢µ»½Ñ³«È¯¤Î±ç½õ

¿å»ºÊª¤Ë¤Ä¤¤¤Æ¤â¡¢Â»¼ºÊä½þ¡¡Ä¾ÀÜ»Ùʧ¤¤¡¡¡Ö¿å»º¶È¡¦µù¼Áí¹çÂкö¡×¤Î¼ùΩ

Í¢½Ð¿å»º»º¶È¤Ø¤ÎÊä½õ¶â¡¡Ä¾ÀÜ»Ùʧ¤¤

¿¼³¤µû³«È¯¡¡±è´ßµù¶È¤Î¶áÂå²½¡¡Î®Ä̵¡¹½¤ÎÀ°È÷¡¡¡¡µ»½Ñ³«È¯¤Î±ç½õ

°Ê¾å

»²¾È¸¡º÷¥­¡¼¥ï¡¼¥É
´Ú¹ñ¤ÎFTA¤¬¤é¤ß¤Ç¤ÎÇÀ²ÈÂкöÈñ

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

̱¼çÅÞ¤µ¤ó¡¢Ä«»°Êë»Í¤ÎÇÀ¶È¼Ô¸ÍÊ̽êÆÀÊä½þÀ©ÅÙÁÏÀߤǤϺ¤¤ê¤Þ¤¹¤è¡£

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 07:25:25

2009/08/26(Wed)
¡¡
null
¡Ö̱¼çÅޤξ®Âô°ìϺÂåɽÂå¹Ô¤Ï£²£µÆü¸á¸å¡¢Æ±ÅÞ¤¬½°±¡Áª¥Þ¥Ë¥Õ¥§¥¹¥È¡ÊÀ¯¸¢¸øÌó¡Ë¤Ç·Ç¤²¤ëÊƹñ¤È¤Î¼«Í³Ëǰ׶¨Äê¡Ê£Æ£Ô£Á¡Ë¤Î¿ä¿ÊÊý¿Ë¤Ë¤Ä¤¤¤Æ¡Ö¤É¤Î¤è¤¦¤Ê¾õ¶·¤Ë¤Ê¤Ã¤Æ¤âÀ¸»º¼Ô¤¬ºÆÀ¸»º¤Ç¤­¤ë¡Ê¸ÍÊ̽êÆÀÊä½þ¡ËÀ©ÅÙ¤ò¤Ä¤¯¤ë¤È¸À¤Ã¤Æ¤ë¤ó¤À¤«¤é¡¢²¿¤Î¿´ÇÛ¤â¤Ê¤¤¡×¤È¶¯Ä´¡¢¡ÖÇÀ²È¤äÀ¸»º¼Ô¤Ï¤ï¤ì¤ï¤ì¤Î¼çÄ¥¤ò¤­¤Á¤ó¤ÈÍý²ò¤·¡¢»Ù»ý¤·¤Æ¤¯¤ì¤ë¤È»×¤¦¡×¤È½Ò¤Ù¤¿¡£¡×
¤È¤¤¤¦¤Î¤À¤¬¡¢¤³¤ÎÏÀÍý¤À¤È¡¢¡Ö¥¢¥á¥ê¥«¤È¤ÎFTA¸ò¾Ä¤Ë¤È¤â¤«¤¯Æþ¤Ã¤Æ¤·¤Þ¤¤¡¢¤½¤³¤Ç¡¢ÇÀ»ºÊª¸ò¾Ä¤Ç¡¢¤É¤Î¤è¤¦¤Ê·ë²Ì¤Ë¤Ê¤Ã¤¿¤È¤·¤Æ¤â¡¢¸ÍÊ̽êÆÀÊä½þ¤Ç¤·¤Î¤²¤ë¡×¤È¤¤¤¦ÏÀÍý¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤¦¡£

¤¤¤Ã¤¿¤¤¡¢FTA¤¬Àè¤Ê¤Î?¸ÍÊ̽êÆÀÊä½þ¤¬Àè¤Ê¤Î? ¤Ã¤Æ¤¤¤¦ÁÇËѤʵ¿Ìä¤òÊú¤¤¤Æ¤·¤Þ¤¦¤Î¤Ï»ä¤À¤±¤Ç¤¢¤í¤¦¤«¡£

¤ªÎ٤δڹñ¤Ç¤Ï¡¢£Æ£Ô£Á¤Ç±Æ¶Á¤ò¼õ¤±¤ëÇÀ²È¤ËÂФ¹¤ëÁêÅö¤Ê±ç½õ¤ò¤ª¤³¤Ê¤Ã¤Æ¤¤¤ë¤¬¡¢ºâÀ¯¾õÂÖ¤ò¹Í¤¨¡¢¤³¤ì°Ê¾å¤Î±ç½õ¤ÏÉÔ²Äǽ¤À¤È¤·¤Æ¤¤¤ë¡£

Åö½é¡¢´Ú¹ñ¤Ï¡¢¥¢¥á¥ê¥«¤È¤ÎFTAÄù·ë¤ËÅö¤¿¤Ã¤Æ¤Î¹ñÆâÇÀ¶È¼Ô¤ÎÂÇ·âÂкö¤È¤·¤Æ¡¢20Ãû¥¦¥©¥ó¤ÎÂкöÈñ¤ò2008ǯ¤«¤é¼Â»Ü¤¹¤ë¤³¤È¤òÁÛÄꤷ¤Æ¤¤¤¿¡£

¤½¤Î¤¦¤Á¡¢12.1Ãû¥¦¥©¥ó¤Ï¡¢´û¸¤Î119Ãû¥¦¥©¥ó¤Î´û¸ÇÀ¶Èͽ»»¤«¤é¤Þ¤«¤Ê¤¦¤È¤·¤Æ¤¤¤¿¡£
»²¹Í
¡ÖGov’t measures to protect agriculture sector from KORUS FTA ¡×
¡ÖU.S.-Korean Food Fight¡×

¤Ê¤ª¡¢´Ú¹ñ¤ÎFTA¤¬¤é¤ß¤Ç¤ÎÇÀ²ÈÂкöÈñ¤Î¾ÜºÙ¤Ë¤Ä¤¤¤Æ¤Ï¡¢»ä¤ÎÊÌ¤Î¥Ö¥í¥°µ­»ö¡Ö´Ú¹ñ¤¬¥¢¥á¥ê¥«¤È¤ÎFTAÄù·ë¤Ç¹Ô¤¦¹ñÆâÂкö¤Î³µÍספò¤´»²¾È¡£

°Ê¾å¤Î¾®Âô¤µ¤ó¤Îȯ¸À¤«¤é´¶¤¸¤é¤ì¤ë¤Î¤Ï¡¢¡¢¤â¤È¤â¤È¡¢¤³¤Î¸ÍÊ̽êÆÀÊä½þ¤ÎÏäϡ¢ÇÀ²È¤Ë¤È¤Ã¤Æ¤Î¡¢Ä«»°Êë»Í¤ÎÏÃ(Ãæ¹ñ¡¢ÁפÎÁÀ¸ø¤¬¡¢»ô¤Ã¤Æ¤¤¤ë±î¤Ë¥È¥Á¤Î¼Â¤òÍ¿¤¨¤ë¤Î¤Ë¡¢Ä«¤Ë»°¤Ä¡¢Êë¤ì¤Ë»Í¤Ä¤ä¤ë¤È¸À¤¦¤È±î¤¬¾¯¤Ê¤¤¤ÈÅܤ俤¿¤á¡¢Ä«¤Ë»Í¤Ä¡¢Êë¤ì¤Ë»°¤Ä¤ä¤ë¤È¸À¤¦¤È¡¢¤¿¤¤¤½¤¦´î¤ó¤À¤È¤¤¤¦)¤Ê¤ó¤Ç¤Ï¤Ê¤«¤Ã¤¿¤ó¤À¤í¤¦¤«¡¢¤È¤¤¤¦¤³¤È¤Ç¤¢¤ë¡£

ÂçÂΡ¢¤³¤Î¤è¤¦¤ÊÏäϡ¢FTA¸ò¾Ä¤ËÆþ¤Ã¤¿¸å¤ÎÇÀ²È¤ËÂŶ¨¤òÇ÷¤ëºÝ¤Î¥¢¥á¤ÎÏäʤó¤Ç¤¢¤Ã¤Æ¡¢¤³¤ì¤«¤é¡¢¥¢¥á¥ê¥«¤È¤ÎFTA¸ò¾Ä¤ËÆþ¤ëÁ°¤Ë¡¢¥»¡¼¥Õ¥Æ¥£¡¼¥Í¥Ã¥È¤È¤·¤ÆÄ󼨤¹¤ëÏäǤϤʤ¤¤ó¤Ç¤Ï¤Ê¤¤¤Ç¤·¤ç¤¦¤«¤Í¡£

Àè¤Ë¤â¤é¤Ã¤¿¥¢¥á¤Û¤É¡¢¸å¤Ë¤Ê¤Ã¤ÆÉݤ¤¤â¤Î¤Ï¤Ê¤¤¤ó¤À¤«¤é¡£


»²¹Í1.
»ä¤Î¥Ö¥í¥°¤Î´ØÏ¢µ­»ö

¡Ö¾®Âô̱¼çÅÞ¤¬·Ç¤²¤ë¸ÄÊ̡ʸÍÊ̡˽êÆÀÊä½þÀ©Å٤ϡ¢ËÇ°×ÏĶÊŪÊä½õ¶â¤Ç¤Ï¤Ê¤¤¤Î¤«?¡×
¡Ö³Ð½ñ-̱¼çÅޤθÍÊ̽êÆÀÊä½þÀ©Å٤ȥ¢¥á¥ê¥«¤ÎľÀÜ¡¦ÉÔ­ʧ¤¤Êä½õ¶âÀ©ÅÙ¡ÊDCP:Direct and Counter-cyclical Payment¡Ë¤È¤Î°ã¤¤¡×
¡ÖWTO¤È¥Ü¥Ã¥¯¥¹¡¦¥·¥Õ¥Æ¥£¥ó¥°µ¬À©¥ë¡¼¥ë¤Ë¤Ä¤¤¤Æ¡×
¡Ö¡Ö¥É¡¼¥Ï¥é¥¦¥ó¥É¹ç°Õ¤òÁÛÄꤷ¤¿ÆüËܤÎÉÊÌܲ£ÃÇŪ·Ð±Ä°ÂÄêÂкö¤Î¥¹¥­¡¼¥à¸«Ä¾¤·¤ÎɬÍ×À­¡×¡×
¡Ö´Ú¹ñ¤ÎFTA»ö¾ð¡×
¡ÖWTO¥É¡¼¥Ï¥é¥¦¥ó¥É¡Ýº£·îËö¤Þ¤Ç¤Ë¡¢²þÄûÈÇ¥Õ¥¡¥ë¥³¥Ê¡¼¡¦¥Æ¥­¥¹¥ÈÄ󼨤θ«Ä̤·¡×
¡Ö¥Ö¥é¥¸¥ë¤È¥«¥Ê¥À¤¬¡¢¤³¤³¤Ë¤­¤Æ¡¢¥¢¥á¥ê¥«¤ÎÇÀ»ºÊª²Á³Ê»Ù»ýÊä½õ¶â¤Ë¤Ä¤¤¤Æ¡¢¥¤¥Á¥ã¥â¥ó¡×
¡Ö10·î£´Æü¤Ë¥¢¥á¥ê¥«¤¬Äó½Ð¤·¤¿²«¿§¤ÎÀ¯ºö(AMS)¤ÈOTDS¤Î¼ÂÀÓ¡×
¡Ö¡ÖÉôʬºÇŬ¡¢Á´Âκǰ­¡×¤ÎÇÀÀ¯¤Ç¤Ï¡¢º¤¤ê¤Þ¤¹¡£¡×
¡Ö¥¢¥á¥ê¥«²¼±¡¤òÄ̲ᤷ¤¿2007ǯÇÀ¶ÈË¡¤Î¥Ý¥¤¥ó¥È¡×
¡ÖWTO¸ò¾Ä¤Ç¡¢¥Õ¥¡¥ë¥³¥Ê¡¼¸ò¾ÄµÄŤ«¤é¥â¥À¥ê¥Æ¥£¡¼¹ç°Õ°ÆÄ󼨡×

»²¹Í2.
£²£°£°£³Ç¯¤ËÄù·ë¤·¤¿ÆüËܤȥᥭ¥·¥³¤È¤ÎFTA¶¨Äê¤ÎÃæ¿È(ÇÀÃÜ»ºÊª»Ô¾ì³«ÊüÉôʬ)

Ìó300¤ÎÉÊÌܤǴØÀÇűÇÑ¡¢ÄãΨ¡¦Ìµ´ØÀǤÎÍ¢ÆþÏȤòÀߤ±¤ë

ÆÚÆù¡¢·ÜÆù¡¢µíÆù¡¢¥ª¥ì¥ó¥¸²Ì½Á¡¦À¸²Ì¤Î¸ÞÉÊÌܤǤϴØÀÇΨ³äÅö¤òŬÍÑ¡¢È¯¸ú¸å5ǯ¸å¤ËºÆ¶¨µÄ

½ÅÍ×ÉÊÌܤǤ¢¤ë¥³¥á¡¢¾®Çþ¡¢¼çÍ×ÆýÀ½ÉÊ¡¢º½Åü¡¢²¹½£¥ß¥«¥ó¡¢¥ê¥ó¥´¡¢¥Ñ¥¤¥Ê¥Ã¥×¥ë¤ÏÎã³°

¡Ö¡¡£Æ£Ô£Á¡¢¡ÖľÀÜ»Ùʧ¤¤¤ÇÇÀ¶È¤ò¸î¤ë¡×¡©¡¢²¤ÊƤϽÅÍ×ÉôÌç¤Î´ØÀÇűÇѤˤϱþ¤¸¤Ê¤¤¡×¤è¤ê

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

2009/08/25 Tuesday

À¤³¦¤Ë¹­¤¬¤ëH1N1¥ï¥¯¥Á¥ó³§Àܼ½¸ÃÄÀܼï¤ÎÆ°¤­

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 20:30:02

2009ǯ8·î25Æü
¡¡
null¤«¤Í¤Æ¤«¤é¥¢¥á¥ê¥«¤Ë¤Ï¡¢H1N1¥ï¥¯¥Á¥ó¤ò¹ṉ̃¤Ë³§Àܼ蘆¤»¤è¤¦¤È¤¹¤ë¹½ÁÛ¤¬¤¢¤Ã¤¿¡£

¤³¤ì¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤ï¤¿¤¯¤·¤Î°ÊÁ°¤Î¥Ö¥í¥°µ­»ö¡Ö¥¢¥á¥ê¥«¤¬Â絬ÌϤʥ說¥Á¥óÀܼï·×²è¡×¤ò¤´»²¾È¤¯¤À¤µ¤¤¡£

ºòÆü¤Î¥ª¥Ð¥ÞÂçÅýÎΤؤÎPCAST¥ì¥Ý¡¼¥È¤Ë¤â¤¢¤ë¤è¤¦¤Ë¡¢¥ï¥¯¥Á¥óÉÔ­¤Ç¤¢¤ë¤Ë¤â¤«¤«¤ï¤é¤º¡¢¤³¤Îή¤ì¤Ï»ß¤Þ¤Ã¤Æ¤¤¤Ê¤¤¤è¤¦¤À¡£

¤à¤·¤í¡¢½£Ã±°Ì¤ä³Ø¹»Ã±°Ì¤Ç¡¢½¸ÃÄÀܼï¤ò¹Ô¤ª¤¦¤È¤¹¤ëÆ°¤­¤â²Ã®¤·¤Æ¤­¤Æ¤¤¤ë¤è¤¦¤À¡£

¥¢¥á¥ê¥«¤Ç¤Ï¡¢½¸ÃÄÀܼï¤Ë¤Ä¤¤¤Æ¤Î¥­¥ã¥ó¥Ú¡¼¥ó¤â¿»Æ©¤·¤Æ¤­¤Ä¤Ä¤¢¤ë¤è¤¦¤À¤¬¡¢Æ±»þ¤Ë¡¢¤½¤ì¤Ë¤Ä¤ì¤Æ¡¢½¸ÃÄÀܼï¤Î¸ùºáÏÀ¤âÉâ¾å¤·¤Æ¤­¤Æ¤¤¤ë¤è¤¦¤À¡£
»²¾È¡ÖReceive Free Neurological Disorder with Your Swine Flu Vaccination¡×

¤½¤·¤Æ¡¢¤³¤³¤Ë¤­¤Æ¡¢¥¢¥á¥ê¥«¤Ð¤«¤ê¤Ç¤Ê¤¯¡¢¤¤¤í¤¤¤í¤Ê¹ñ¤Ë¡¢¹ṉ̃³§Àܼï¤Ê¤ê½¸ÃÄÀܼï¤ÎÆ°¤­¤¬½Ð¤Æ¤­¤Æ¤ª¤ê¡¢¤Þ¤¿¡¢¤½¤ì¤Ë¤Ä¤¤¤Æ¤Î¸ùºáÏÀ¤â½Ð¤Æ¤­¤Æ¤¤¤ë¤è¤¦¤À¡£

¤Þ¤º¡¢¥«¥Ê¥À¤Ç¤¢¤ë¤¬¡¢¥¢¥ë¥Ð¡¼¥¿½£¤Ç¡¢³Ø¹»¤ÎÀ¸Å̤ËÂФ·¤Æ¡¢³§Àܼï¥×¥í¥°¥é¥à¤òÍÑ°Õ¤¹¤ëÆ°¤­¤¬¤¢¤ë¡£

¤·¤«¤·¡¢¤³¤ì¤Ë¤Ï°Õ¸«¤¬¤¤¤í¤¤¤í¤¢¤ë¤è¤¦¤Ç¡¢¸Ç¤Þ¤Ã¤¿¤â¤Î¤Ç¤Ï¤Ê¤¤¡£

È¿Âаո«¤È¤·¤Æ¤Ï¡¢º£²ó¤Î¿··¿¤Ï¡¢µ¨ÀáÀ­¤è¤ê¤â¼å¤¤ÆÇÀ­¤ò¤â¤Ä¤Î¤À¤«¤é¡¢É¬Íפʤ¤¡¢¤Ê¤É¤¬¤¢¤ë¡£

1957ǯ¤Î½¸Ãĥ說¥Á¥óÀܼï¤ÎºÝ¤Î¥Þ¥¤¥Ê¥¹¤Î¶µ·±¤òÀ¸¤«¤»¤È¤¤¤¦¤³¤È¤À¤í¤¦¡£

¤·¤«¤·¡¢¤¤¤Ä¤¤¤«¤Ê¤ë¤È¤­¤Ë¤â¡¢½¸ÃÄÀܼï¤Î¼Â»Ü¤¬¤Ç¤­¤ë¤è¤¦¤Ë¡¢¥ï¥¯¥Á¥ó¤Î³ÎÊݤϤ·¤Æ¤ª¤¯¤È¤¤¤¦¤³¤È¤Î¤è¤¦¤À¡£

»²¾È¡ÖSchools could be sites of mass vaccinations¡×

¥Ö¥ê¥Æ¥£¥Ã¥·¥å¥³¥í¥ó¥Ó¥¢½£¤Ç¤Ï¤â¤Ã¤È¥·¥ê¥¢¥¹¤Ê¤È¤é¤¨Êý¤ò¤·¤Æ¤¤¤Æ¡¢¤³¤Îʬ¤Ç¤Ï¡¢ºÇ°­¡¢¥¯¥ê¥¹¥Þ¥¹¤Þ¤Ç³Ø¹»¤òÊĺ¿¤·¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¤È¤Þ¤Ç¤¤¤Ã¤Æ¤¤¤ë

¤·¤«¤·¡¢¤½¤Î¤³¤È¤Ë¤è¤ë¼Ò²ñŪ¤Ê¥³¥¹¥È¤â¹Í¤¨¡¢¤³¤³¤Ç¤â¡¢¥ï¥¯¥Á¥ó½¸ÃÄÀܼï·×²è¤ò¼ùΩÃæ¤Ç¤¢¤ë¤È¤¤¤¦¡£
»²¾È¡ÖKids going back to school will cart H1N1 with them: BC medical officer¡×

¼¡¤Ë¥ª¡¼¥¹¥È¥é¥ê¥¢¤Ç¤¢¤ë¤¬¡¢¤¹¤Ç¤Ë½¸ÃÄÀܼï·×²è¤Ï¿Ê¤ó¤Ç¤¤¤ë¤¬¡¢¹ñÆâŪµÄÏÀ¤È¤·¤Æ¡¢¿··¿¥ï¥¯¥Á¥óÀܼï¤Ë¤ª¤¤¤Æ¡¢Ä̾ïÆó²ó¤Î¤â¤Î¤ò¡¢°ì²ó¤Ë¸º¤é¤·¤Æ¡¢¤¤¤ÁÁ᤯¡¢¹­¤¤ÈϰϤǽ¸ÃÄÀܼï¤ò¼Â»Ü¤¹¤Ù¤­¤È¤ÎµÄÏÀ¤¬¤¢¤ë¤è¤¦¤À¡£

»²¹Í¡ÖExperts warn against hasty H1N1 flu vaccine¡×
¡ÖNo H1N1 ‘urgency’ exists and vaccine strategy ‘risky’ doctors say¡×

¥¤¥®¥ê¥¹¤Ç¤Ï¡¢10·î¤Ë°ìÀé»°É´Ëü¿Í¤òÂоݤ˽¸ÃÄÀܼ郎·×²è¤µ¤ì¤Æ¤¤¤ë¤¬¡¢¤³¤³¤Ë¤­¤Æ¡¢Í­¼±¼Ô¤«¤é¡¢½¸ÃÄÀܼï¤ËÂФ¹¤ë¿µ½ÅÏÀ¤¬À¯ÉܤËÂФ·¤Æ½Ð¤µ¤ì¤Æ¤¤¤ë¤è¤¦¤À¡£

¥¢¥á¥ê¥«¤Ç¤Î1976ǯ¤ÎÂ缺ÇÔ(1976’s debacle)¤ò·«¤êÊÖ¤¹¤Ê¡¢¤È¤¤¤¦¤è¤¦¤ÊÏÀÄ´¤Ç¡¢½¸ÃÄÀܼï¤Ë¤è¤ë´í¸±À­¤ò¶¯Ä´¤·¤Æ¤¤¤ë¡£

»²¹Í¡ÖSwine flu vaccine linked to deadly nerve disease?¡×

¥¹¥¦¥§¡¼¥Ç¥ó¤Ï¡¢°ì²¯»ÍÀéÆóÉ´Ëü¥É¥ë¤Îͽ»»¤òÀߤ±¤Æ¡¢9·îËö¤«¤é10·î¤Ë¤«¤±¤Æ¡¢¶åÉ´Æó½½Ëü¿ÍÂоݤ˽¸ÃÄÀܼï¤ò¤¹¤ë¤³¤È¤Ë¤·¤¿¡£
»²¹Í¡ÖSweden allocates extra funds for swine flu vaccinations ¡×

¤¶¤Ã¤È¸«¤Æ¡¢¤³¤Î¤è¤¦¤Ê¾õ¶·¤Î¤è¤¦¤Ç¤¢¤ë¤¬¡¢¤³¤Î¤è¤¦¤Ê³§ÀܼïÏÀ¤ä½¸ÃÄÀܼïÏÀ¤¬¹­¤Þ¤ì¤Ð¹­¤Þ¤ë¤Û¤É¡¢À¤³¦Åª¤Ê¥ï¥¯¥Á¥ó¤ÎÉÔ­¤È¡¢³Æ¹ñ¤ï¤ìÀè¤ÎÆþ¼ê·¹¸þ¤¬¶¯¤Þ¤ë¤È¤¤¤¦¤ï¤±¤À¡£

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¥ª¥Ð¥ÞÂçÅýÎΤËÄó½Ð¤µ¤ì¤¿H1N1¤Ë´Ø¤¹¤ëPCAST¥ì¥Ý¡¼¥È¤Î³µÍ×

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 16:36:35

2009/08/25(Tue)
¡¡
null¥ª¥Ð¥ÞÊÆÂçÅýÎΤβʳص»½Ñ»ðÌä°Ñ°÷²ñ¡Ê£Ð£Ã£Á£Ó£Ô¡Ë¤¬¡¢¤³¤ì¤Þ¤Ç¤Ë¤Þ¤È¤á¤Æ¤¤¤¿Êó¹ð½ñ¤òºòÆü¥ª¥Ð¥ÞÂçÅýÎΤËÄó½Ð¤·¤¿¡£

86¥Ú¡¼¥¸¤Ë¤ï¤¿¤ëPCAST¤ÎÊó¹ð½ñ¤ÎÁ´Ê¸¤Ï¡¢¤³¤Î¥µ¥¤¥È
¡ÖREPORT TO THE PRESIDENT¡¡ON U.S . PREPARATIONS FOR¡¡2009-H1N1 INFLUENZA¡×
¤Ë¤¢¤ë¡£

Êó¹ð½ñ¤Î³µÍפϡ¢¼¡¤Î¤È¤ª¤ê¤Ç¤¢¤ë¡£

2009ǯH1N1¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹¤Ï¡¢1918¡Ý1919ǯ¤Î¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤È¤Ï¡¢°Û¤Ê¤ë¤â¤Î¤Î¤è¤¦¤Ë¸«¤¨¤ë¡£

¤·¤«¤·¡¢1976ǯ¤ÎBenign(ØÀØé)¤Ê¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹¤È¤Ï°Û¤Ê¤Ã¤Æ¡¢¹ñ²ÈŪ¶¼°Ò¤È¤Ê¤ê¤¦¤ë¤â¤Î¤Ç¤¢¤ë¡£

¤½¤ì(¶¼°Ò)¤Ï¡¢º£²ó¤Î¥¦¥¤¥ë¥¹¤ÎÃ×»àÀ­¤Ë¤¢¤ë¤Î¤Ç¤Ï¤Ê¤¯¡¢´¶À÷³ÈÂçÀ­¤Ë¤¢¤ë¤«¤é¤À¡£

¤³¤Î¤³¤È¤Ï¡¢Â¿¤¯¤Î¿Í¤ËÌȱ֤¬¤Ê¤¤¤¿¤á¤Ë¡¢°åÎÅ»ÜÀߤ¬Ëþ°÷¤Ë¤Ê¤ë²ÄǽÀ­¤òÈë¤á¤Æ¤¤¤ë¡£

¤½¤³¤Ç¡¢PCAST¤È¤·¤Æ¤ÎºÇÂç¤Î´«¹ð¤Ï¡¢

­¡¥ï¥¯¥Á¥óʬÇÛ¤ò¥Ï¥¤¥ê¥¹¥¯¤Î¿Í¤ËÍ¥ÀèŪ¤ËʬÇÛ¤¹¤ë¤³¤È¡£
­¢¹³¥¦¥¤¥ë¥¹Ìô¤Î»ÈÍѤˤĤ¤¤Æ¤Î¥¬¥¤¥É¥é¥¤¥ó¤òÌÀ³Î¤Ë¤¹¤ë¤³¤È¡¢
­£¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤Î¿ÊŸ¾õ¶·¤òÄÉÀפ·¤Æ¤¤¤ë¸½ºß¤Î¥·¥¹¥Æ¥à¤ò¥¢¥Ã¥×¥°¥ì¡¼¥É¤¹¤ë¤³¤È¡£
­¤¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤Î¾×·â¤ò´ËϤ·¤¦¤ë¸ø½°±ÒÀ¸¾ðÊó¤ÎÅÁÇŤò ¶¯²½¤·¤¦¤ë¥¦¥§¥Ö¡¦¥Ù¡¼¥¹¤Ç¤Î¥½¡¼¥·¥ã¥ë¥Í¥Ã¥È¥ï¡¼¥¯¤äÊüÁ÷¤ò´Þ¤à¹­Êó³èÆ°Àïά¤ò¿ÊŸ¤µ¤»¤ë¤³¤È¡£
­¥¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤Î¿ÊŸ¤Ëȼ¤Ã¤Æ¡¢À¯ÉÜÆâÃæ¤Ç¤Î½ÅÍ×·èÄê¤òÅý¹ç¤¹¤ë¤Î¤¬¥Û¥ï¥¤¥È¥Ï¥¦¥¹¤Îï¤Ê¤Î¤«¤òÌÀ³Î¤Ë¤¹¤ë¤³¤È¡£

¤Ç¤¢¤ë¡£

Æä˶¯Ä´¤¹¤Ù¤­¤Ï¡¢³Ø¹»¶µ°é¤Î¸½¾ì¤Ë¤ª¤±¤ë¥­¥ã¥ó¥Ú¡¼¥ó¤ò¶¯²½¤¹¤ë¤³¤È¤Ç¤¢¤ë¤È¤·¤Æ¤¤¤ë¡£

Êó¹ð½ñ¤ÎÌܼ¡¤Ï²¼µ­¤Î¤È¤ª¤ê

I. Introduction and Charge
II. The U.S. Experience with Influenza Over the Last Century
III. Anticipating the Return of 2009-H1N1: Envisioning Scenarios
IV. Ensuring Adequate Data for Decision Making: Surveillance Systems
V. Responding to the Pandemic
VI. Lowering Financial and Regulatory Barriers to Effective Response
VII. Improving Communications
VIII. Planning for More Effective Future Strategies Against Influenza

»²¹Í
¡ÖPresident¡Çs Council of Advisors on Science and Technology (PCAST)
releases report assessing H1N1 preparations
¡×

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

2009/08/23 Sunday

¼«Ì±ÅÞ»´ÇÔ¸å¤ÎÀ¯¶É¤Ï?

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 06:27:38

2009/08/23(Sun)
¡¡
nullÊóÆ»¤Ï¡¢¤¤¤º¤ì¤â¡¢¤¹¤Ç¤Ë¡¢¼«Ì±Åޤλ´ÇÔ¤¬·è¤Þ¤Ã¤¿¤è¤¦¤Ê½ñ¤­¤Ö¤ê¤À¤¬¡¢¤ª¤½¤é¤¯¡¢¤½¤¦¤Ê¤Î¤À¤í¤¦¡£
1986ǯ6·î¤ÎÃæÁ¾º¬Æâ³Õ¤Ë¤è¤ë»à¤ó¤À¤Õ¤ê²ò»¶¤Ç¤Ï¡¢¼«Ì±ÅÞ¤¬300µÄÀʤò³ÍÆÀ¤·¡¢Â羡¤·¤¿¤Î¤À¤¬¡¢¤ª¤½¤é¤¯¡¢º£²ó¤ÎÁíÁªµó¤Ï¡¢Ì±¼çÅÞ¤¬¤³¤ì¤ò¾å²ó¤ëµÄÀʤò³ÍÆÀ¤¹¤ë¤Î¤Ç¤¢¤í¤¦¡£

¤¢¤Î»þ¤Ï¡¢ÁíÁªµó¸å¤Ë¡¢¡Ö¤¤¤«¤Ë¤·¤Æ¤ï¤ì¤ï¤ì¤Ï¡¢300µÄÀʤòÆÀ¤¿¤«¡×¤Ê¤É¤È¤¤¤¦Ê¬ÀÏ¥ì¥Ý¡¼¥È¤òÆɤޤµ¤ì¤¿µ­²±¤¬¤¢¤ë¡£
¤½¤Î»°Ç¯¸å¤Î1989ǯ¤Î»²µÄ±¡µÄ°÷Áªµó¤Ç¤Ï¡¢Îã¤Î¤ª¤¿¤«¤µ¤ó¥Ö¡¼¥à¤Ç¡¢Âç»´ÇÔ¤À¤Ã¤¿¤Î¤À¤«¤é¡¢¤ï¤«¤é¤Ê¤¤¤â¤Î¤Ç¤¢¤ë¡£

¤È¤Ë¤«¤¯¡¢¾¡¤Á¤¹¤®¡¦¾¡¤¿¤»¤¹¤®¤Ï¡¢Áªµó¸å¤ÎÀ¯¶É±¿±Ä¤ò¡¢¤«¤¨¤Ã¤Æ²²É¤ʤâ¤Î¤Ë¤µ¤»¤Æ¤·¤Þ¤¦¤â¤Î¤À¡£
¤³¤ì¤Þ¤Ç¤ÎÎã¤ò¸«¤Æ¤â¡¢É÷¤ÇÅöÁª¤·¤¿µÄ°÷¤¬¡¢¼¡´üÁªµó¤ÇºÆÁª¤µ¤ì¤ë³ÎΨ¤Ï¡¢¤­¤ï¤á¤ÆÄ㤤¤Î¤À¤«¤é¡£
Æä˽÷À­µÄ°÷¤Î¾ì¹ç¤Ï¡¢¤ª¤¿¤«¤µ¤ó¥Ö¡¼¥àµî¤Ã¤¿¸å¤Îµî½¢¤ò¸«¤ì¤Ð¤è¤¯¤ï¤«¤ë¡£
¥®¥ê¥®¥ê¾¡¤Á¾å¤¬¤ê¤Ã¤Æ·Á¤¬°ìÈ֤褫¤Ã¤¿¤Î¤À¤¬—

¤ª¤½¤é¤¯¡¢º£²ó¤ÎÁíÁªµó¸å¤Î̱¼çÅޤ⡢¾®Àô¥Á¥ë¥É¥ì¥ó¤Î̱¼çÅÞÈǤΤ褦¤Ê¡¢±¦¤âº¸¤â¤ï¤«¤é¤Ê¤¤Í­¾Ý̵¾Ý(Ãݲ¼ÅФµ¤ó¤Ï¡¢¤³¤¦¤¤¤¦Êý¡¹¤ò¡Ö±à»ù¡×¤È¾Î¤µ¤ì¤Æ¤·¤Þ¤·¤¿¤Ã¤±¡£)¤¬¤Ò¤·¤á¤­¹ç¤Ã¤Æ¤¤¤ë¤¦¤Á¤Ë¡¢¤¤¤í¤¤¤í¤ÊÌäÂ꤬ËÖȯ¤·¤Æ¡¢¼«²õ¤¬À¸¤¸¤ë¤è¤¦¤Ê¤³¤È¤Ë¤Ê¤ë¤Î¤À¤í¤¦¡£

¤Ê¤Ë¤·¤í¡¢º£²ó¤ÎÁíÁªµó¤Ï¡¢¹ṉ̃¤Ë¤È¤Ã¤Æ¤ÎÍý¶þÈ´¤­¤Ç¤Î¡ÖÍ«¤µÀ²¤é¤·Áªµó¡×¤Ê¤Î¤À¤«¤é¡£
¤½¤·¤Æ¡¢Ì±¼çÅޤϡ¢¤½¤Î¹ṉ̃¤ÎÍ«¤µÀ²¤é¤·¤Î¼õ¤±»®¤Î¤¿¤á¤Î¡Ö¤ä¤à¤òÆÀ¤¶¤ëÂåÂØÀ¯Åޡפ˲᤮¤Ê¤«¤Ã¤¿¤ï¤±¤À¤«¤é¡¢

¤½¤¦¤Ç¤¢¤ì¤Ð¡¢»´ÇÔ¤¹¤ë¤Ç¤¢¤í¤¦¼«Ì±Åޤ⡢¤¤¤ÁÁ᤯³Ð¸ç¤ò·è¤á¤Æ¡¢°áÂؤ¨¤Ê¤ê¡¢Ê¬ÅÞ²½¤Ê¤ê¡¢»ý¤Á³ô¥Û¡¼¥ë¥Ç¥£¥ó¥°²½¤Ê¤ê¡¢¤Ê¤É¤·¤Æ¡¢¿·¤·¤¤º£ÆüŪ¤Ê¥¹¥­¡¼¥à¤Ç¼¡´ü¤ËΩ¤Á¸þ¤«¤¨¤Ð¡¢Éü¸¢¤â˾¤ß¤Ê¤­¤Ë¤·¤â¤¢¤é¤º¤Ê¤Î¤À¤í¤¦¡£

¼«Ì±ÅޤϤʤ¯¤Ê¤Ã¤Æ¤â¡¢¼«Ì±ÅÞ¹¥¤ß¤ÎÀ¯³¦¤Î¥Þ¡¼¥±¥Ã¥È¤È¤¤¤¨¤ë¤â¤Î¤Ï¡¢°ÍÁ³¡¢»Ä¤µ¤ì¤Æ¤¤¤ë¤Î¤À¤«¤é¡£

¤½¤·¤Æ¡¢¹¬¤«ÉÔ¹¬¤«¡¢Ì±¼çÅÞ°µ¾¡¤È¤Ê¤ì¤Ð¡¢Àè¤Î¿·¿ÊÅޤλþ¤ß¤¿¤¤¤Ë¡¢Ì±¼çÅÞ¤«¤é¤Î°ú¤­È´¤­¤Ë¤¢¤¦¤³¤È¤â¤Ê¤¤¤ó¤Ç¡¢¼«Ì±ÅޤξƤ±À×¥Þ¡¼¥±¥Ã¥È¤Ï¡¢¤Û¤È¤ó¤É¼êÉÕ¤«¤º¤Î¤Þ¤Þ»Ä¤µ¤ì¤ë¤È¤¤¤¦¹¬±¿¤¬¤¢¤ë¡£

̱¼çÅÞ¤è¤ê¤â¤ä¤ä±¦¤è¤ê¤Î°áÂؤ¨À¯ÅޤΥ³¥¢¤Ê¤ó¤Æ¤Î¤Ï¡¢¤¤¤È¤â´Êñ¤Ë¤Ç¤­¤½¤¦¤Ê´¶¤¸¤À¡£

¾Æ¤±Àפ˥Хé¥Ã¥¯¤ò·ú¤Æ¤ë¤è¤¦¤Ê¤â¤ó¤À¡£(¤¨¤Ã?µÜºêÃϷܥХé¥Ã¥¯Å¹¤À¤Ã¤Æ?)

¤¤¤ï¤Ð¡¢º£²ó¤ÎÁªµó¤Ï¡¢¼«Ì±ÅޤˤȤäƤϾÆȪÁªµó¤È¹Í¤¨¤ì¤Ð¡¢¾Æ¤­¿Ô¤¯¤µ¤ì¤ì¤Ð¤µ¤ì¤ë¤Û¤É¡¢¼¡²ó¤Ë¿·¤·¤¤¿·²ê¤¬½Ð¤Æ¤­¤ä¤¹¤¤¡¢¤È¤¤¤¦¤³¤È¤Ê¤Î¤À¤í¤¦¡£

¤Þ¤¢¡¢¼«Ì±ÅޤˤȤäƤϡ¢¡ÖÆàÎɤμãÁð»³Áªµó¡×¤È¤Ç¤â¤¤¤¦¤ó¤À¤í¤¦¤«¡£

´±Î½¤Ë¤È¤Ã¤Æ¤Ï¤É¤¦¤Ê¤Î¤À¤í¤¦?

º£¤Î»þÅÀ¤Ç¤Ï¡¢´±Î½¤¤¤¸¤á¤á¤¤¤¿¡¢¤¤¤í¤¤¤í¤ª¤É¤í¤ª¤É¤í¤·¤¤¸ÀÍÕ¤¬Ì±¼çÅޤδ´Éô¤Î¸ý¤«¤éÈô¤Ó½Ð¤·¤Æ¤¤¤ë¤¬¡¢¤à¤·¤í¡¢´±Î½¤Ë¤È¤Ã¤Æ¤Ï¡¢¸æ¤·¤ä¤¹¤¤Áê¼êÊý¤Ê¤Î¤«¤È¤â»×¤ï¤ì¤ë¡£

´±Î½¤Î¤·¤¿¤¿¤«¤µ¤ËÈ椷¤Æ¡¢Ì±¼çÅޤϡ¢¤¢¤ó¤Þ¤ê¤Ë¤âÄË¡¹¤·¤¤½ã¤Ã¤Æ´¶¤¸¤Ê¤â¤ó¤Ç¡¢²Ì¤¿¤·¤Æ¤É¤ó¤Ê¤â¤ó¤Ê¤Î¤À¤í¤¦¤«?

¤½¤ì¤È¤â¡¢¤³¤ì¤«¤éÍèǯÅÙͽ»»¤Î³µ»»Í×µá¤Îºî¤êľ¤·¤Ç¤â¤¹¤ë¤ó¤À¤í¤¦¤«?

¸½ºß¡¢Ì±¼çÅޤθý¤«¤é½Ð¤Æ¤¤¤ë¥Ð¥é¥Þ¥­¤Îɽ»æʬ¤À¤±¼Â¹Ô¤·¤Æ¡¢¼Â¼ÁŪ¤Ê¥¤¥ó¥»¥ó¥Æ¥£¥Ö¤Ï¡¢²¿¤âÍ¿¤¨¤Ê¤¤¤è¤¦¤Ê¥¹¥­¡¼¥àºî¤ê¤Î·ÝÅö¤Ï¡¢º£¤Î´±Î½¤Ë¤È¤Ã¤Æ¤Ï¡¢¤¤¤È¤â¡¢¤¿¤ä¤¹¤¤¤³¤È¤Î¤è¤¦¤Ë¤â¸«¤¨¤ë¡£

¤´¿Ê¹Ö¤¹¤ë¦¤«¤é¤µ¤ì¤ë¦¤Ë¥·¥Õ¥È¤·¤Æ¡¢¤¸¤Ã¤È̱¼çÅÞ¤«¤é¤Î¤´¿Ê¹Ö¤ò¤Þ¤Ã¤Æ¤¤¤ì¤Ð¤¤¤¤¤À¤±¤ÎÏäǤ¢¤ë¡£

À¯¼£¼çƳ¤Ç´¹¹üÂÄÂۤˤè¤ëºâ¸»ºî¤ê¤Þ¤Ç¤·¤Æ¤¯¤ì¤ë¤Ã¤Æ¸À¤¦¤ó¤À¤«¤é¡¢Ìò¿Í¤Ë¤È¤Ã¤Æ¤Ï¡¢¤½¤Îºâ¸»ÂÔ¤Á¤·¤«¤Ê¤¤¤ó¤¸¤ã¤Ê¤¤¤Î¤«¤Ê?

¡Ö¤¢¤Î¡¼¡Ý¡Ý¡£ºâ¸»¤Î½ÐÁ°¤Þ¤À¤Ã¤¹¤«?¡×¤Ã¤Æ´¶¤¸¤Ç¤·¤ç¤¦¤«¤Í¡£

Àï¸å¤Î¥Ñ¡¼¥¸¸å¤ÎÏÂÅÄÇîͺ¤µ¤ó¤Î¤è¤¦¤Ê³×¿·´±Î½¤È¤¤¤¦¤è¤¦¤Ê¤â¤Î¤Ï¡¢¤ª¤½¤é¤¯¡¢¸½¤ì¤Ê¤¤¤è¤¦¤Êµ¤¤¬¤¹¤ë¡£

¤â¤Ã¤È¤â¡¢»þ¤ÎÀ¯¸¢¤ÎÔÌÍÀË«ìʤǰú¤­È´¤«¤ì¤¿´±Î½¤ÎËöÏ©¤Ë¤Ï¡¢¤¢¤ó¤Þ¤ê¤¤¤¤¤â¤Î¤¬¤Ê¤¤¤è¤¦¤Êµ¤¤¬¤¹¤ë¡£

¤³¤ÎÏÂÅĤµ¤ó¤Ë¤·¤Æ¤â¡¢¤½¤·¤Æ¾®ÀôÀ¯¸¢»þ¤Î͹À¯Ì±±Ä²½¤Îw***¤µ¤ó¤Ë¤·¤Æ¤â—

Ãæ¹ñŪ¤ÊŤ¤ÌܤǸ«¤ì¤Ð¡¢Ì±¼çÅÞÀ¯¸¢¤Ë¤Ê¤Ã¤¿¤«¤é¤È¤¤¤Ã¤Æ¡¢¤½¤ó¤Ê¤ËÉ⤭­¤À¤Ã¤Æ·¯»ÒÉ¿ÊѤ·¡¢»¤¤ê´ó¤ë´±Î½¤Ï¡¢¤½¤ó¤Ê¤Ë¿¤¯¤Ï¤¤¤Ê¤¤¤ó¤À¤í¤¦¡£

Âè°ì¡¢¤¤¤¯¤é»¤¤ê´ó¤Ã¤¿¤Ã¤Æ¡¢Å·²¼¤ê¶Ø»ß¤Ç¤Ï¡¢´Î¿´¤Î¡ÖÂ࿦¸å¤Î¥´¡¼¥ë¥Ç¥ó¥¿¥¤¥à¡×¤Ø¤Î¥¤¥ó¥»¥ó¥Æ¥£¥Ö¤¬¤¹¤Ã¤«¤êÈ´¤±Íî¤Á¤Æ¤·¤Þ¤Ã¤Æ¤¤¤ë¤ó¤Ç¤Ï¤Í¡£

¤»¤¤¤¼¤¤¡¢Ì±¼çÅÞ¤µ¤ó¤ª¹¥¤ß¤Î¡ÖÊä½õ¶â¤Î»ºÄ¾²½¡×Ū¥¹¥­¡¼¥à¤òºî¤Ã¤Æ¤Ï¡¢Ì±¼çÅÞ¤µ¤ó¤«¤é¤Î¶½¤òÇ㤦¤³¤È¤ËÅؤá¤ë¤¯¤é¤¤¤Î¤³¤È¤Ê¤Î¤À¤í¤¦¡£

¤½¤ÎÅÀ¤ÏÌÀ¼£°Ý¿·¤È¤Ï°Û¤Ê¤ë¤ó¤À¤í¤¦¡£

¤¤¤ï¤Ð¡¢µ¿»÷ŪÀ¯¸¢¸òÂå´ü´Ö¤Ë¤¢¤ë¤È¤¤¤¦Ç§¼±¤Ç¤¤¤¤¤ó¤Ç¤Ï¤Ê¤«¤í¤¦¤«?

¤Ä¤Þ¤ê¡¢¤³¤ó¤Ê¤½¤ó¤Ê¤À¤«¤é¡¢Ì±¼çÅޤϡ¢¥Þ¥Ë¥Õ¥§¥¹¥È¤ÇÄ󼨤·¤¿¥Ð¥é¥Þ¥­(¥Ð¥é¥Þ¥­¤È¤Ï¡¢¸ÀÍÕ¤òÊѤ¨¤Æ¤¤¤¨¤Ð¡¢¡ÖÉôʬºÇŬ¡¢Á´Âκǰ­¡×¤Ç¤¢¤ë¡£)¤Î¥¤¥ó¥Ç¥Ã¥¯¥¹ºî¤ê¡¦Ìܼ¡ºî¤ê¤Þ¤Ç¤Ï¡¢²¿¤È¤«¤³¤®¤Ä¤±¤é¤ì¤½¤¦¤Ç¤¢¤í¤¦¤¬¡¢¤½¤ÎÀè¤Ï¡¢¤Ê¤ó¤È¤â±À³¤¤ÎÃæ¡¢¤È¤¤¤Ã¤¿¤È¤³¤Ê¤ó¤Ç¤Ï¤Ê¤«¤í¤¦¤«¡£

¤Ð¤é»µ¤­¥Þ¥Ë¥Õ¥§¥¹¥È¼Â¹Ô¤Ë¤è¤ë¡¢¹ṉ̃¤Ë¤È¤Ã¤Æ¤Î¥³¥â¥ó¥º¤ÎÈá·à¤Ï¤³¤ì¤«¤é»Ï¤Þ¤ë¤Î¤À¡£

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

2009/08/21 Friday

¥ï¥¯¥Á¥óʬÇۤκÇŬ²½

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 09:55:17

2009ǯ8·î21Æü
¡¡
nullH1N1¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥ï¥¯¥Á¥ó¤ÎÀ½Â¤¤¬ÃÙ¤ì¤Æ¤¤¤ë¤Î¤Ï¡¢²¿¤â¡¢ÆüËܤФ«¤ê¤Ç¤Ï¤Ê¤¤¡£

¥¢¥á¥ê¥«¤Ç¤â¡¢10·î15Æü¤Þ¤Ç¤ËÍѰդǤ­¤ë¥ï¥¯¥Á¥ó¤Ï¡¢»ÍÀé¸ÞÉ´Ëü¿Íʬ(°ì¿ÍÆó²óÀܼï¤Ç¡¢ÍÑ°Õ¤µ¤ì¤Æ¤¤¤ë¤Î¤Ï¶åÀéËüÉþ¡¢Åö½é¤ÎºÇ½é¤ÎÀܼïÂоÝͽÄê¼Ô¿ô¤Ï°ì²¯Ï»ÀéËü¿Í)¤Ë²á¤®¤Ê¤¤¤È¤¤¤¦¡£

¤½¤Î¸å¤Ï¡¢°ì½µ´Ö¤´¤È¤ËÆóÀéËüÉþ¤¬ÄɲäËÍÑ°Õ¤µ¤ì¤ë¤È¤¤¤¦¡£

¤½¤³¤Ç¡¢º£ÏÃÂê¤Ë¤Ê¤Ã¤Æ¤¤¤ë¤Î¤¬¡Ö¥ï¥¯¥Á¥óʬÇۤκÇŬ²½¡×¤È¤¤¤¦²ÝÂê¡£

ºòÆü¤ÎScience¤ÇÏÃÂê¤È¤µ¤ì¤¿(¡Ö¥µ¥¤¥¨¥ó¥¹¤Ëȯɽ¤·¤¿¡×¤Î¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¤Í¡£¥µ¥¤¥¨¥ó¥¹¤Î¥µ¥¤¥È¤Î¤Ê¤«¤Î¡ÖScience Podcast¡×¤È¤¤¤¦²»À¼¥é¥¸¥ª¤Ç¡¢¤³¤Î¸¦µæ¼ÔJan Medlock¤È¤Î¥¤¥ó¥¿¥Ó¥å¡¼¤¬¤¢¤ê¡¢ÏÃÂê¤Ë¤Ê¤Ã¤¿¤È¤¤¤¦¤³¤È¤Ç¤¹¡£¤ªÊ¹¤­¤Ë¤Ê¤ê¤¿¤¤Êý¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¡£¤Þ¤¿¡¢¥é¥¸¥ª¤ÎÆâÍƤòʸ¾Ï¤ÇÃΤꤿ¤¤Êý¤Ï¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¡£¤½¤Î¤Ø¤ó¡¢ÆüËܤΥޥ¹¥³¥ß¤â¡¢¸¶Åµ¤òÅö¤¿¤Ã¤Æ¤¤¤Ê¤¤¤Î¤«¡¢¤¤¤¤¤«¤²¤ó¤Ç¤¹¤Í¡£)¤Î¤¬¡¢Yale and Clemson universities¤ÎJan Medlock¤µ¤ó¤È¡¢Alison P. Galvani ¤µ¤ó¤Î¡ÖOptimizing Influenza Vaccine Distribution ¡×¤È¤¤¤¦ÏÀʸ¡£

¤³¤ÎÏÀʸ¼«ÂΤϡ¢º£·î8·î3Æü¤Ëȯɽ¤Ë¤Ê¤Ã¤¿¤â¤Î¤é¤·¤¤¡£

¿ô³Ø¼Ô¤Î¤è¤¦¤À¡£

¥ï¥¯¥Á¥ó¤ÎºÇ½é¤ÎʬÇÛ¤¬¡¢5ºÐ¤«¤é19ºÐ¤Î»Ò¶¡¤È¡¢30ºÐ¤«¤é39ºÐ¤ÎÂç¿Í¤ËʬÇÛ¤µ¤ì¤ë¤È¡¢ºÇŬ²½¤µ¤ì¤ë¤È¤¤¤¦¤Î¤À¤¬¡£

Á°Äó¤È¤·¤Æ¡¢º£²ó¤ÎH1N1¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤¬¡¢1957ǯ¤Î¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤è¤ê¤â¸·¤·¤¯¡¢1918ǯ¤Î¥Ñ¥ó¥Ç¥ß¥Ã¥¯¤è¤ê¤â¡¢¼å¤¤¡¢¤È¤·¤Æ

1¿Í¤Î´¶À÷¼Ô¤¬¡¢Â¾¿Í¤Ë´¶À÷¤ò¤¦¤Ä¤¹¤Î¤Ï¡¢1.4¿Í¤È¤·¤Æ

1Æü¤¢¤¿¤ê¡¢7290¿Í¤Î¿Í¡¹¤¬97904¿Í¤Î´¶À÷¼Ô¤òÀ¸¤à¡¢¤È¤¤¤¦´ªÄê¤Ë¤Ê¤ë¡£

¤³¤³¤Ç¡¢Æ±À¤Âå´Ö¤Î´¶À÷¤Î¥ß¥­¥·¥ó¥°¤¬ÌÔÎõ¤Ë¤ª¤­¤ë¤Î¤Ï¡¢³Ø¹»¤Î¥¯¥é¥¹¥á¡¼¥È´Ö¤È¡¢¤½¤ì¤é¤ÎÀ¸Å̤¿¤Á¤¬²ÈÄí¤Ëµ¢¤Ã¤Æ¤Î¡¢¤½¤ì¤¾¤ì¤Îξ¿Æ¤È¤Î´Ö¤Ç¤¢¤ë¡¢¤È¸«¤ë¡£

¤½¤³¤Ç¡¢¤³¤ì¤é¤Î´¶À÷¤Î¥ß¥­¥·¥ó¥°¤¬µ¯¤­¤ë²ÄǽÀ­¤Î¶¯¤¤À¤Âå¤Ë¡¢Í¥ÀèŪ¤Ë¥ï¥¯¥Á¥óÀܼï¤ò¤·¤Æ¤¤¤±¤Ð¡¢¸ú²ÌŪ¤È¤Ê¤ë¤È¤¤¤¦¤Î¤¬Èà¤é¤ÎÍýÏÀ¤Ç¡¢¤³¤Î·×»»¤Ë¤è¤ë¤È¡¢¥¢¥á¥ê¥«Á´Åڤǡ¢¤³¤ÎÀ¤Âå¤ËɬÍפȤµ¤ì¤ë¥ï¥¯¥Á¥ó¤Ï¡¢Ï»ÀéÆóÉ´ËüÉþ¤«¤éÏ»Àé»°É´ËüÉþ¤Ç¤¹¤à¤È¤¤¤¦¡£

¤½¤³¤Çµ¤¤Ë¤Ê¤ë¤Î¤Ï¡¢¤³¤Î¿ô³Ø¼Ô¤Î¥â¥Ç¥ë¤ËÂФ¹¤ëCDC¤Îɾ²Á¤À¤¬¡¢CDC¤Ç¤Ï¡¢¡Ö¤ï¤ì¤ï¤ì¤¬ºÎÍѤ·¤Æ¤¤¤ë¤Î¤Ï¡¢Ã±°ì¥â¥Ç¥ë¤Ç¤Ï¤Ê¤¤¡£Â¿¤¯¤ÎÁ°Äó¾ò·ï¤ò¹Íθ¤·¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡£¡×¤È°ì½³¤·¤Æ¤¤¤ë¤è¤¦¤À¡£

»²¹Í
¡ÖThe CDC should rethink its H1N1 vaccination strategy, study says¡×
¡ÖStudy questions U.S. flu vaccine guidelines¡×
¡ÖFlu Shot Targets Should Be Kids, Parents¡×
¡ÖStudy: Vaccinating school kids best to stop flu¡×

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

2009/08/20 Thursday

¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤Ë¤Ä¤¤¤Æ¤ÎÀµ³Î¤ÊÄêµÁ¤¬É¬Í×

Filed under: ̤ʬÎà — ´ÉÍý¿Í @ 11:02:12

2009ǯ8·î20Æü
¡¡
null°ÊÁ°¡¢ ¤ï¤¿¤¯¤·¤Î¥Ö¥í¥°µ­»ö
¡Öή¹ÔÀ­Ç¾ÀÔ¿ñËì±ê¤Ã¤Æ¤Ê¤ó¤À?¡×
¤ä
¡Ö¡ÖºÙ¶ÝÀ­¿ñËì±ê¡¢ÆüËܤâ¥ï¥¯¥Á¥ó¾µÇ§¤Ø¡×¤È¤¤¤¦Ä«Æü¿·Ê¹¤Îµ­»ö¤Ë¤Ä¤¤¤Æ¡×
¤Î¤Ê¤«¤Ç¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤È¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¿ñËì±ê¤È¤òº®Æ±¤¹¤ë¿Í¤¬Â¿¤¤¤Î¤Ç¡¢¤½¤ÎÀµ³Î¤Ê°ã¤¤¤ò¤Î¤Ù¤¿¤³¤È¤¬¤¢¤Ã¤¿¡£

¤Þ¤¿¡¢¤½¤ÎÀá¤Ï¡¢¼ÂºÝ¡¢¿ñËì±ê¤Ë¤«¤«¤Ã¤¿¤ª»ÒÍͤò¤â¤Ä¼çÉؤΤ«¤¿¤Ê¤É¤«¤é¤â¡¢¥á¡¼¥ë¤ò¤¤¤¿¤À¤­¡¢¤³¤Îɵ¤¤Î»ý¤Ä¿¼¹ï¤µ¤ò¿È¶á¤Ë´¶¤¸¤ë¤³¤È¤È¤Ê¤Ã¤¿¡£

¤³¤³¤ËÍè¤Æ¡¢º£Å٤ϡ¢Á´¹ñ³ÆÃϤǡ¢H1N1¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶´¶À÷¤Ëȼ¤¦¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤òȯ¾É¤¹¤ë»Ò¤É¤â¤¬Áý¤¨¤Æ¤­¤Æ¡¢ÊóÆ»³Æ»æ¤â¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤Ë¤Ä¤¤¤Æ¤Îµ­»ö¤ò½ñ¤¤¤Æ¤¤¤ë¤Î¤À¤¬¡¢¤½¤ì¤é¤Îµ­ºÜ¤ÎÃæ¤Ë¤Ï¡¢¡ÖµÞÀ­Ç¾±ê(¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É)¡×¤Ê¤É¤È¤Îµ­ºÜ¤â¤¢¤Ã¤¿¤ê¤·¤Æ¡¢ÂоݤλҶ¡¤µ¤ó¤ò¤â¤¿¤ì¤ë¿Æ¸æ¤µ¤ó¤Ë¤Ï¡¢¸í²ò¤òÍ¿¤¨¤ëÀá¤â¡¢¸«¤é¤ì¤ë¡£

¤¢¤ë¤¤¤Ï¡¢°Ê²¼¤Ë½Ò¤Ù¤ëIAE¤ÈANE¤È¤Î°ã¤¤¤ò̵»ë¤·¤¿½ñ¤­Êý¤ò¤·¤Æ¡¢¿Æ¸æ¤µ¤ó¤Ë²á¾ê¤Ë¿´ÇÛ¤òÍ¿¤¨¤ë½ñ¤­Êý¤ò¤·¤Æ¤¤¤ëµ­»ö¤â»¶¸«¤µ¤ì¤ë¡£

¤½¤³¤Ç¡¢¤³¤³¤Ë¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤Ë¤Ä¤¤¤Æ¤Î¡¢Àµ³Î¤ÊÄêµÁ¤ò¤·¤Æ¤ª¤¯É¬Íפ¬¤¢¤ë¤È»×¤¦¡£

¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤ÈǾ±ê¡¦¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¿ñËì±ê¤È¤Ï°Û¤Ê¤ë

¤Þ¤º¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤ÈǾ±ê(¥Ø¥ë¥Ú¥¹Ç¾±ê¤Ê¤É)¤È¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¿ñËì±ê¤È¤Ï¡¢¤¤¤º¤ì¤â°Û¤Ê¤ë¤â¤Î¤Ç¤¢¤ë¤³¤È¤òǧ¼±¤¹¤ëɬÍפ¬¤¢¤ë¤â¤Î¤È»×¤ï¤ì¤ë¡£

Ǿ±ê¤Ï¡¢¥¦¥¤¥ë¥¹¤Ê¤É¤Îɸ¶ÂΤ¬¡¢Ä¾ÀÜ¡¢Ç¾¤Ë±ê¾É¤òµ¯¤³¤¹¤â¤Î¤Ç¤¢¤ê

¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¿ñËì±ê¤Ï¡¢¿ñËì¤ä·ì´É¼þ°Ï¤Î±ê¾É¤òµ¯¤³¤¹¤â¤Î¤Ç¤¢¤ë¤¬
¡¢
¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤Ï¡¢¤³¤Î¾åµ­¤Î¤¤¤º¤ì¤Ç¤â¤Ê¤¯¡¢

·ì´ÉÆâÈéºÙ˦¤¬¾ã³²¤òµ¯¤³¤¹¤³¤È¤Ë¤è¤ë¤â¤Î¤Ç¤¢¤ë¡£

¤³¤Î¾ì¹ç¡¢¥¦¥¤¥ë¥¹´¶À÷¤Ë¤è¤Ã¤Æ¡¢·ìÃæ¤ä¿ñ±ÕÃæ¤Ë¡¢±ê¾ÉÀ­¤Î¥µ¥¤¥È¥«¥¤¥ó¡¢¥µ¥¤¥È¥«¥¤¥ó¼õÍÆ´ï¤òÁý²Ã¤µ¤»¡¢¤³¤Î¤³¤È¤Ç¡¢·ì´ÉÆ©²áÀ­¤òж¿Ê¤µ¤»¡¢·ì´ÉÆâÈéºÙ˦¤¬³èÀ­²½¤µ¤»¤é¤ì¤¿¤ê¡¢¾ã³²¡Ê¥¢¥Ý¥È¡¼¥·¥¹-ºÙ˦¤Î¼«ÌÇ»à-¤¬µ¯¤³¤ë¡Ë¤òÀ¸¤¸¤µ¤»¤¿¤ê¤¹¤ë¤³¤È¤Ç¡¢·ìÀò¤Ê¤É¤¬·ÁÀ®¤µ¤ì¤ä¤¹¤¯¤Ê¤ë¤¿¤á¤Ë¡¢Ç¾¾É¤¬µ¯¤³¤ë¤â¤Î¤È¤µ¤ì¤Æ¤¤¤ë¡£

¶á»þ¤Ë¤Ê¤Ã¤Æ¡¢³ËË칦¤¿¤ó¤Ñ¤¯¼Á¡ÌRan Binding Protein 2 (RANBP2)¡Í¤ÎÊÑ°Û¤ò¸¶°ø¤È¤¹¤ëÀâ¤â¤¢¤ë¤è¤¦¤À¡£
»²¹Í¡ÖInfection-Triggered Familial or Recurrent Cases of Acute Necrotizing Encephalopathy Caused by Mutations in a Component of the Nuclear Pore, RANBP2¡×

¤Ê¤ª¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤ËÂбþ¤·¤¿¥ï¥¯¥Á¥ó¤Ï¤Ê¤¤¤Î¤Ç¡¢¤ª´Ö°ã¤¤¤Ê¤¤¤è¤¦¤Ë¡£
(¤É¤¦¤â¡¢¤³¤ÎÅÀ¤Ëº®Í𤬤¢¤ë¤Î¤Ï¡¢¤ª¤½¤é¤¯¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¿ñËì±êÂбþ¤ÎHib¥ï¥¯¥Á¥ó¤Ë¡¢Ì¾Á°¤À¤±¤Ï¡¢¡Ö¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¶Ý£â·¿¡Ê£È£é£â)Âбþ¡×¤È¤Ä¤¤¤Æ¤¤¤ë¤»¤¤¤Ê¤Î¤Ç¤·¤ç¤¦¡£¤Ç¤â¡¢¤³¤Á¤é¤Î£È£é£â¤Î¤Û¤¦¤Ï¡¢¥¦¥¤¥ë¥¹¤Ç¤Ï¤Ê¤¯¡¢¥Ø¥â¥Õ¥£¥é¥¹Â°(Haemophilus) ¤Î¥Ð¥¯¥Æ¥ê¥¢¤Ç¤¢¤ë¤Î¤Ç¤¯¤ì¤°¤ì¤â¤ª´Ö°ã¤¤¤Ê¤¤¤è¤¦¤Ë¡£¤«¤Ä¤Æ¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Î¸¶°ø¤È´Ö°ã¤ï¤ì¤¿¤¿¤á¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Î̾¤¬ÉÕ¤¤¤¿¤Þ¤Þ¤Ê¤ó¤Ç¤¹¤Í¡£ËÜÅö¤Ëʶ¤é¤ï¤·¤¤¤Ç¤¹¡£)

¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Ëȼ¤¦Ç¾¾É¤Ë¤ÏIAE¤ÈANE¤È¤¬¤¢¤ë

º£²ó¤ÎH1N1¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Ëȼ¤¦Ç¾¾É¤Ï¡¢Àµ³Î¤Ë¤Ï¡¢
­¡¡ÖInfluenza-associated encephalopathy; IAE¡Ë¡×(¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹´ØϢǾ¾É)
¤Þ¤¿¤Ï
­¢¡ÖInfluenza A virus-associated acute necrotizing encephalopathy¡¨ANE¡×(µÞÀ­²õ»àÀ­Ç¾¾É)
¤È¸Æ¤Ð¤ì¤ë¤â¤Î¤À¡£

­¡¤È­¢¤È¤Î°ã¤¤¤Ç¤¢¤ë¤¬¡¢­¢¤Ï¡¢­¡¤è¤ê¤â¡¢¤«¤Ê¤ê½ÅÆƤʾõÂ֤Ǥ¢¤ë¡£
­¡¤«¤é­¢¤Ø¤È¿ÊŸ¤·¤¦¤ë°ìÂΤΤâ¤Î¤È¹Í¤¨¤¿¤Û¤¦¤¬¤¤¤¤¤è¤¦¤À¡£
­¡¤ÎÃʳ¬¤Ç¤È¤É¤á¤é¤ì¤ë¤è¤¦¤ÊÁá´ü¼£ÎŤ¬É¬ÍפΤ褦¤À¡£

¤Ê¤¼ÆüËܿͤË¿¤¤¤Î¤«

¤³¤ì¤é¤Î¤¤¤º¤ì¤â¡¢½¾Íè¤Ï¡¢¥¢¥¸¥¢¤ËÆÃÍ­¤Ë¸«¤é¤ì¤¿Éµ¤¤Ç¤¢¤Ã¤¿¤¬¡¢¶áǯ¡¢ËÌÊƤˤ⸫¤é¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¤è¤¦¤À¡£

¥¢¥¸¥¢¤ÎÃæ¤Ç¤Ï¡¢ÆüËܤ¬°ìÈÖ¿¤¯¡¢Â³¤¤¤ÆÂæÏѤ¬Â¿¤¤¤è¤¦¤À¡£

³¤¤¤Æ¤Ï¡¢¥¢¥á¥ê¥«¡¢¥«¥Ê¥À¡¢¥è¡¼¥í¥Ã¥Ñ¤È¤¤¤Ã¤¿¤È¤³¤í¤À¤¬¡¢¾ÉÎã¤Ï¾¯¤Ê¤¤ÍͤÀ¡£

¤Ê¤¼¥¢¥¸¥¢¿Í¤Ë¿¤¤¤Î¤«¤Ï¡¢½ôÀ⤢¤ë¤è¤¦¤À¤¬¡¢
­¡°äÅÁ»ÒŪÆüÁ¤Ë¤è¤ë¤â¤Î¡¢
­¢ÆüËܿͤ¬¡¢¥¨¥Õ¥§¥É¥ê¥ó¡¢¥¸¥¯¥í¥Õ¥§¥Ê¥¯¥Ê¥È¥ê¥¦¥à(Diclofenac Sodium)¥¢¥¹¥Ô¥ê¥ó¡ÊÂç¿ÍÍѥХե¡¥ê¥ó¤Ê¤É¡Ë¤Ê¤É¤òÂçÎÌÉþÍѤ·¤Æ¤¤¤¿¤ê¡¢¶¯¤¤²òÇ®ºÞ¡Ì¥Ý¥ó¥¿¡Ý¥ë(¥á¥Õ¥§¥Ê¥à»À)¤ä¥Ü¥ë¥¿¥ì¥ó(¥¸¥¯¥í¥Õ¥§¥Ê¥¯Na)¡Í¤ò»Ò¤É¤â¤Ë½èÊý¤·¤Æ¤¤¤¿¤³¤È
¤Ê¤É¤¬¤¢¤²¤é¤ì¤Æ¤¤¤ë¡£

¤Þ¤¿¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶B·¿´ØÏ¢¤è¤ê¤â¡¢°µÅÝŪ¤Ë¥¤¥ó¥Õ¥ë¥¨¥ó¥¶A·¿´ØÏ¢¤¬Â¿¤¤¤Î¤À¤¬¡¢¤½¤ÎÍýͳ¤Ï¤è¤¯¤ï¤«¤é¤Ê¤¤¤è¤¦¤À¡£

´µ¼Ô¤Ë¤Ï¡¢A·¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¡¦¥¦¥¤¥ë¥¹¤È¥Ò¥È¥Ø¥ë¥Ú¥¹¥¦¥¤¥ë¥¹6¡ÊHHV-6¡Ë¤Þ¤¿¤Ï¡¢¥Ò¥È¥Ø¥ë¥Ú¥¹¥¦¥¤¥ë¥¹7¡ÊHHV-7¡Ë(¤¤¤º¤ì¤â¥Ø¥ë¥Ú¥¹Ç¾±ê¤Î¸¶°ø¤È¤Ê¤ë¥¦¥¤¥ë¥¹)¤È¤Ë¡¢¤È¤â¤Ë½ÅÊ£´¶À÷¤·¤Æ¤¤¤ëÎ㤬¤¢¤ë¤¬¡¢¤½¤Î´Ø·¸¤Ë¤Ä¤¤¤Æ¤â¡¢¤Þ¤À¡¢¤è¤¯¤ï¤«¤Ã¤Æ¤¤¤Ê¤¤¤è¤¦¤À¡£

ANE¤Î̾ÉÕ¤±¿Æ¤Ï¡¢ÆüËܤοå¸ý²í¤µ¤ó

¤³¤Î­¢¤Î¡ÖInfluenza A virus-associated acute necrotizing encephalopathy¡¨ANE¡×(µÞÀ­²õ»àÀ­Ç¾¾É)¤ò¤Ê¤º¤±¤¿¤Î¤¬¡¢°Õ³°¤Ë¤â¡¢ÆüËܿͤοå¸ý²í¤µ¤ó¤Ç¤¢¤ë¡£

¿å¸ý¤µ¤ó¤Î¸¦µæ¥°¥ë¡¼¥×¤Ï¡¢1995ǯ¤ËJ Neurol Neurosurg Psychiatry»ï¤Ë¤ª¤¤¤Æ¡¢¡ÖAcute necrotizing encephalopathy of childhood:a new syndrome presenting with multifocal, symmetric brain lesions¡×¤È¤ÎÏÀʸ(ÆüËܸì¤Ç¤Ï¡¢¡Ö¾®»ùµÞÀ­²õ»àÀ­Ç¾¾É¡×¾®»ùÆâ²Ê28(8): 1125-1129, 1996.)¤òȯɽ¤·¤Æ¤¤¤ë¡£

¿ÇÃÇ´ð½à¡¦¾É¾õ¡¦ÉÂÍý³ØŪÆÃħ

ANE¤Ë¤Ä¤¤¤Æ¤Î¿ÇÃÇ´ð½à¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Î¥µ¥¤¥È¡ÖFinal Diagnosis — Influenza associated acute necrotizing encephalopathy¡×¤Ë¡¢¿å¸ý¤µ¤ó¤Î¿ÇÃÇ´ð½à¤â¸ò¤¨¤Æ¡¢¾Ü¤·¤¯¾Ò²ð¤µ¤ì¤Æ¤¤¤ë¡£

Æäˡ¢µÞÀ­²õ»àÀ­Ç¾¾É(ANE)¤ÈÎà»÷¾É¾õ¤ò¸«¤»¤ë¡¢µÞÀ­»¶ºßÀ­Ç¾ÀÔ¿ñ±ê(ADEM)¤äµÞÀ­½Ð·ìÀ­Çò¼ÁǾ±ê(AHLE)¤È¤Î¸«Ê¬¤±¤¬¥­¡¼¥Ý¥¤¥ó¥È¤Î¤è¤¦¤Ç¤¢¤ë¡£

°Ê¾å¤Î­¡­¢¤ò°ìÂΤΤâ¤Î¤È¤·¤Æ¤ß¤ë¤È¡¢¤½¤Î¾É¾õ¤Ï
1.ȯǮ¡¢
2.µÞ®¤Ê°Õ¼±¾ã³²¤ÈáÛÚ»¡¢È¯ºî¡¡
3.³±.
4.ÓÒÅÇ¡¡
5.²¼Î¡
¤Ç¤¢¤ë¡£

ÉÂÍý³ØŪÆÃħ(pathological feature )¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Î¥µ¥¤¥È¡ÖSummary of the neuropathology of ANE in the acute stage¡×¤Ë¡¢2009ǯ3·î(¤Þ¤À¡¢º£²ó¤Î¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹¤¬¸øɽ¤µ¤ì¤ëÁ°¤Î»þÅÀ)¤Ç¤ÎOvid Medline ¤Î10¾ÉÎ㤬¤Þ¤È¤á¤é¤ì¤¤¤ë¡£

Øí´µ¤·¤¿»Ò¤É¤â¤Î¶¦ÄÌÅÀ¤Ï?

¤³¤ì¤é¤Î¾ÉÎ㤫¤é¡¢ANE¤ËØí´µ¤·¤¿»Ò¤É¤â¤¿¤Á¤Ë¤Ï¡¢»°¤Ä¤Î¶¦ÄÌÅÀ¤¬¸«¤é¤ì¤¿¤È¤¤¤¦¡£

­¡²áµî¤Ëµ¤´É»ÙÓé¡¢¥¢¥È¥Ô¡¼¤ò»ý¤Ã¤Æ¤¤¤¿¡£
­¢¿À·Ð¾É¾õ¤ò¤¢¤é¤ï¤¹Ä¾Á°¤Ë¡¢¥×¥ì¥É¥Ë¥¾¥í¥ó(prednisolone) ¤ä¡¡¥»¥ì¥¹¥¿¥ß¥ó(celestamine)¤Ê¤É¤ÎÌȱÖÄ´ÀáÌô¤òÉþÍѤ·¤Æ¤¤¤¿¡£
­£Æó½µ´Ö°ÊÆâ¤ËA·¿ H3 ¤äH1 ¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Ë¤«¤«¤Ã¤Æ¤¤¤¿¡£

¤Ê¤Ë¤Ï¤È¤â¤¢¤ì¡¢¤Þ¤º¥¿¥ß¥Õ¥ë¤ò

ANE¤ÎÃ×»àΨ¤Ï¡¢28-30¥Ñ¡¼¥»¥ó¥È¤È¹â¤¤¡£

¼£ÎÅË¡¤È¤·¤Æ¤Ï¡¢·èÄêŪ¤Ê¼£ÎŤȤϤʤ餺¡¢»Ù»ýŪ(Supportive)¤Ê¼£ÎŤˤȤɤޤ뤬

1.¹³¥¦¥¤¥ë¥¹Ìô¤Ë¤è¤ë¼£ÎÅ¡¢
2.¥á¥Á¥ë¥×¥ì¥É¥Ë¥½¥í¥ó¥Ñ¥ë¥¹ÎÅË¡(Methylprednisolone Pulse Therapy)
3.Ìȱ֥°¥í¥Ö¥ê¥ó(IgG)¤ÎÂçÎÌÅêÍ¿
4.¥³¥ë¥Á¥³¥¹¥Æ¥í¥¤¥ÉÂçÎÌÅêÍ¿

¤Ê¤É¤¬¤¢¤ë¡£

²¼µ­¤ÎCDC¥ì¥Ý¡¼¥È¤Ç¤ÎÎã¤â¤¢¤ë¤¬¡¢
¡Ø°ì¹ï¤âÁᤤ¹³¥¦¥¤¥ë¥¹Ìô¤ÎÅêÍ¿¤ò¡Ù
¤È¤¤¤¦¤Î¤¬¥­¡¼¥Ý¥¤¥ó¥È¤Î¤è¤¦¤Ç¤¢¤ë¡£

¥¢¥á¥ê¥«¤ÎCDC¤ÎÊó¹ð½ñ¤Ç¤Ï?

¤Ê¤ª¡¢¥¢¥á¥ê¥«¤ÎCDC¤Ç¤Ï¡¢Àè·î7·î24Æü¤ÎMMWR¥ì¥Ý¡¼¥È¡ØNeurologic Complications Associated with Novel Influenza A (H1N1) Virus Infection in Children — Dallas, Texas, May 2009¡Ù¤Ë¤ª¤¤¤Æ¡¢¥¢¥á¥ê¥«¹ñÆâ¤ÇH1N1¹çÊ»¾É¤È¤·¤Æ¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤òȯ¾É¤·¤¿4¿Í¤Î´µ¼Ô¤ÎʬÀϤò¤·¤Æ¤¤¤ë¡£

¤³¤ì¤Ï¡¢¥Æ¥­¥µ¥¹½£¥À¥é¥¹¡¦¥«¥¦¥ó¥Æ¥£Æâ¤Îɱ¡¤ËÆþ±¡¤·¤¿7ºÐ¤«¤é17ºÐ¤Þ¤Ç¤Î4¿Í¤Î´µ¼Ô¤Î¾ÉÎã¤Ë¤Ä¤¤¤ÆÊó¹ð¤·¤¿¤â¤Î¤Ç¡¢´¶À÷¤·¤¿¼Ô¤Î¤¦¤Á¡¢Ç¾ÀÔ¿ñ±Õ¤Ë¤Ç¤Ï¤Ê¤¯¡¢É¡°öƬ¸¡ÂΤ˥¦¥¤¥ë¥¹¤¬¸¡½Ð¤µ¤ì¤¿´µ¼Ô¤Ë¤Ä¤¤¤Æ¤ß¤Æ¤ß¤ë¤È¡¢¤½¤Î¤¦¤Á¤Î»°¿Í¤Ë¡¢°Û¾ï¤ÊǾÇÈ¿Þ¤¬¸«¤é¤ì¤¿¤È¤¤¤¦¡£

4¿Í¤Ï¡¢¤¹¤Ù¤Æ¡¢¹³¥¦¥¤¥ë¥¹Ìô(¥¿¥ß¥Õ¥ë¤Ï4¿ÍÁ´°÷¤Ë¡¢¥¢¥Þ¥ó¥¿¥¸¥ó¤Ï3¿Í¤Ë¡¢½èÊý)¤Ë¤è¤Ã¤Æ¡¢¤Ê¤ó¤é¤Î¿À·Ð¾É¾õ¤â¤Ê¤¯¡¢²óÉü¤·¡¢Âౡ¤·¤¿¤È¤¤¤¦¡£

¤³¤Î¤³¤È¤«¤é¡¢¤³¤ÎÊó¹ð½ñ¤Ç¤Ï¡¢º£²ó¤ÎH1N1¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¡¦¥¦¥¤¥ë¥¹¤Î´¶À÷¤Ë¤è¤Ã¤Æ¡¢¸ÆµÛ´ï´¶À÷¾É¤È¤Ê¤Ã¤¿¸å¡¢¿À·Ð·Ï¤Î¹çÊ»¾É¤òµ¯¤³¤¹¤³¤È¤¬¤¢¤ë¡¢¤È¤¤¤¨¤ë¤È¤·¤Æ¤¤¤ë¡£

¤½¤·¤Æ¡¢Æä˻Ҥɤâ¤Ë¤ª¤¤¤Æ¤Ï¡¢¸¶°øÉÔÌÀ¤Îȯºî¤äÀº¿À¾õÂÖ¤ÎÊѲ½¤òȼ¤Ã¤¿¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¾õ¤Î¾É¾õ¤¬¤¢¤Ã¤¿¾ì¹ç¤Ë¤Ï¡¢Î×¾²°å¤Ï¡¢´µ¼Ô¤è¤ê¤Î¸ÆµÛ´ï¸¡ÂΤò´ÕÊÌ¿ÇÃǤˤޤ魯¤È¤È¤â¤Ë¡¢¤½¤Î¸¡ºº·ë²Ì¤òÂÔ¤¿¤Ê¤¤¤Ç¡¢¿×®¤Ë¡¢¹³¥¦¥¤¥ë¥¹Ìô¤ÎÅêÍ¿¤ËÅö¤¿¤ë¤Ù¤­¤Ç¤¢¤ë¡¢¤È¤·¤Æ¤¤¤ë¡£

¤Ê¤ª¡¢¤³¤Î¥¢¥á¥ê¥«¤ÎCDCÊó¹ð½ñ¤Ë¤Ä¤¤¤Æ¤Î¥¤¥®¥ê¥¹¤ÎNHS Choices¤Îɾ²Á¤¬¤³¤Î¥µ¥¤¥È¡ÖBrain problems from swine flu ¡×¤Ë¤¢¤ë¡£

º£²ó¤ÎH1N1´ØÏ¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¤Ë¤Ä¤¤¤Æ¤Î¡¢À¤³¦¤Ç¤Î¸ø¼°Åª¤ÊÊó¹ð½ñ¤Ï¡¢¤³¤ÎCDC¤Î¤â¤Î¤À¤±¤Î¤è¤¦¤Ç¤¢¤ë¤¬¡¢¤½¤ì¤Ë¤·¤Æ¤â¡¢ÆüËܤǤξÉÎ㤬¿¤¤¤Î¤¬µ¤¤Ë¤«¤«¤ë¤È¤³¤í¤À¡£

»²¹Í

1..º£Æü¤Þ¤Ç¤ÎÆüËܹñÆâ¤Ç¤ÎH1N1¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶´ØϢǾ¾Éȯ¾É¼Ô°ìÍ÷(¿ï»þ¹¹¿·)

¤Ê¤ª¡¢¸üÀ¸Ï«Æ¯¾Ê¤Îȯɽ¤Ç¤Ï¡¢8·î21Æü¸½ºß¤Îȯ¾ÉÎã¤Ï6Îã¤È¤·¤Æ¤¤¤ë¡£

01ÎãÌÜ¡¡7·î19Æü¡¡Àîºê»ÔÆâ¤Î¾®³ØÀ¸Ã˻һùƸ¡Ê£·¡Ë
02ÎãÌÜ¡¡7·î23Æü¡¡ÆÊÌÚ¸©Ë§²ì·´¤Î¾®³ØÀ¸½÷»Ò»ùƸ
03ÎãÌÜ¡¡7·î24Æü¡¡ÂçºåÉÜ´ßÏÂÅĻԤξ®³Ø£²Ç¯Ã˻һùƸ¡Ê£·¡Ë
04ÎãÌÜ¡¡8·î04Æü¡¡ÂçºåÉÜË­Ãæ»Ô¤ÎÍÄÃÕ±à¤ÎÃË»ù¡Ê£µ¡Ë
05ÎãÌÜ¡¡8·î11Æü¡¡°ñ¾ë¸©¤ÎÃË»ù¡Ê4¡Ë
06ÎãÌÜ¡¡8·î14Æü¡¡µÜºê»ÔÆâ¤ÎÃæ³Ø£²Ç¯ÃË»ÒÀ¸ÅÌ¡Ê£±£´¡Ë
07ÎãÌÜ¡¡8·î19Æü¡¡Àîºê»Ô¤ÎÃË»ù(6)
08ÎãÌÜ?8·î20Æü¡¡²­Æ졦ͿÆá¹ñÅç¤ÎÃËÀ­¡Ê£´£·¡Ë
09ÎãÌÜ¡¡8·î22Æü¡¡ÀéÍÕ¸©»Ô¸¶»Ô¤Î¾®£²½÷»ù¡Ê£·¡Ë
10ÎãÌÜ?8·î24Æü¡¡²­Æ졦ËÜÅç(ÆîÉôÊÝ·ò½ê´ÉÆâºß½»)¤ÎÃ˻Ҿ®³ØÀ¸¡Ê£¸¡Ë
£±£±ÎãÌÜ¡¡£¸·î27Æü¡¡´ä¼ê¸©°ì¸ÍÄ®¤Î½÷»ÒÃæ³ØÀ¸(12)
12ÎãÌÜ¡¡8·î31Æü¡¡°¦Ãθ©½ÕÆü°æ»Ô¤Î¾®³ØÀ¸ÃË»ù¡Ê£¹¡Ë
13ÎãÌÜ¡¡8·î31Æü¡¡ÀŲ¬¸©¾ÆÄŻԤÎÃË»ù¡Ê£´¡Ë
14ÎãÌÜ¡¡9·î01Æü¡¡ÆÊÌÚ¸©ÂÀÅĸ¶»Ô(¸©ËÌ·ò¹¯Ê¡»ã¥»¥ó¥¿¡¼´ÉÆâ)Ã˻Ҿ®³ØÀ¸
15ÎãÌÜ¡¡9·î01Æü¡¡ÆàÎɻԤξ®³Ø£²Ç¯À¸ÃË»ù¡Ê£·¡Ë
16ÎãÌÜ¡¡9·î02Æü¡¡ÀŲ¬¸©ÀŲ¬»ÔÀ¶¿å¶è¤ÎÃË»ù¡Ê£¶¡Ë
£±£·ÎãÌÜ¡¡£¹·î0£¸Æü¡¡¿ÀÆàÀ²£ÉͻԤξ®³Ø£µÇ¯À¸¤ÎÃË»ù¡Ê£±£±¡Ë
18ÎãÌÜ¡¡9·î14Æü¡¡¿ÀÆàÀʿÄͻԤν÷»ù(5)
19ÎãÌÜ¡¡£¹·î£±£¹Æü¡¡¼¢²ì¸©¼é»³»Ô¤Î¾®³Ø£±Ç¯ÃË»ù¡Ê£·¡Ë¡Ý£²£²Æü»àË´
£²£°ÎãÌÜ¡¡£¹·î£²£´Æü¡¡Ï²λ³»Ô¤ÎÃË»ÒÃæ³ØÀ¸(12)
£²1ÎãÌÜ 9·î25Æü¡¡µþÅÔ»ÔÀ¾µþ¶è¤Î½÷»ù¡Ê£¶¡Ë
£²2ÎãÌÜ¡¡9·î25Æü¡¡µþÅÔ»ÔË̶è¤ÎÃË»ù¡Ê£²¡Ë
£²3ÎãÌÜ¡¡9·î25Æü¡¡Ë̳¤Æ»¹¾Ê̻Ԥν÷»ù(9)
24ÎãÌÜ¡¡9·î25Æü¡¡´ä¼ê¸©²Ö´¬»Ô¤Î½÷»Ò»ùƸ¡Ê£±£°¡Ë
25ÎãÌÜ¡¡9·î29Æü¡¡ÆÊÌÚ¸©±§ÅԵܻԤν÷»Ò¾®³ØÀ¸
26ÎãÌÜ¡¡10·î01Æü¡¡ÂçºåÉܹâÄлԤÎÃË»ù(5)
27ÎãÌÜ¡¡10·î06Æü¡¡²£ÉÍ»ÔÀÄÍÕ¶è¤ÎÃË»ù(10)
28ÎãÌÜ¡¡10·î09Æü¡¡²£Éͻ԰ë»Ò¶è¤Î½÷»ù¡Ê£´¡Ë
29ÎãÌÜ¡¡10·î09Æü¡¡¿·³ã»Ô¤ÎÃ˻Ҿ®³ØÀ¸¡Ê£¸¡Ë
30ÎãÌÜ¡¡10·î13Æü¡¡ÅìµþÅÔ¤ÎÃË»ù(4)-»àË´
31ÎãÌÜ¡¡10·î14Æü¡¡°¦Ãθ©À¶¿Ü»Ô¤ÎÃ˻ҹ⹻À¸¡Ê£±£¶¡Ë-»àË´
32ÎãÌÜ¡¡10·î14Æü¡¡Ê¼¸Ë¸©À¾µÜ»Ô¤Î¾®³Ø£²Ç¯¤Î½÷»Ò»ùƸ¡Ê£¸¡Ë-»àË´
33ÎãÌÜ¡¡10·î22Æü¡¡ÅìµþÅÔ¤ÎÃË»ù(3)-»àË´
34ÎãÌÜ¡¡10·î£²£¸Æü¡¡Ê¡Å縩¸©ËÌÃÏÊý¤ÎÃË»ù
35ÎãÌÜ¡¡11·î04Æü¡¡¿·³ã¸©¿·³ã»Ô¤ÎÍÄ»ù3¿Í
38ÎãÌÜ¡¡11·î08Æü¡¡ºë¶Ì¸©¿¼Ã«»Ô¤ÎÃË»ù(3)-»àË´
39ÎãÌÜ¡¡11·î13Æü¡¡»°½Å¸©°Ë²ì»Ô¤Î½÷»ù(À¸¸å9¥ö·î)-»àË´
40ÎãÌÜ¡¡11·î18Æü¡¡ÆÊÌÚ¸©¤ÎÃËÀ­(60ºÐÂå)-»àË´
41ÎãÌÜ¡¡11·î25Æü¡¡¼¯»ùÅ縩¤Î½÷À­(30ºÐÂå)-»àË´
42ÎãÌÜ¡¡11·î25Æü¡¡ÆÊÌÚ¸©¤Î¾®³Ø2ǯÀ¸½÷»Ò(8)-»àË´

2.James J. SejvarÇî»Î¤È¤Î¼Áµ¿±þÅú

¡ÖQ&A with CDC Neuroepidemiologist James J. Sejvar, MD¡×¤Î¥Ó¥Ç¥ª¤è¤ê

³µÌõ

¼ÁÌä
H1N1¤Î¹çÊ»¾É¤ËµÞÀ­¤Þ¤¿¤ÏÃÙȯÀ­¤Î¿À·ÐÀ­¹çÊ»¾É¤Ï¸«¤é¤ì¤Þ¤¹¤«?

Åú¤¨
¤³¤ì¤Þ¤Ç¤Î¤È¤³¤í¡¢H1N1¤Ë¤ª¤¤¤Æ¤Ï¡¢¿À·Ð¾å¤Îɵ¤¤ä»ö¾Ý¤Ï¸«¤é¤ì¤Æ¤¤¤Ê¤¤¡£
¤·¤«¤·¤Ê¤¬¤é¡¢¿Ê¹ÔÃæ¤Î¥µ¡¼¥Ù¥¤¥é¥ó¥¹¤Ë¤ª¤¤¤Æ¤Ï¡¢¤³¤ì¤é¤ÎÀøºßŪ¤Ê¹çÊ»¾É¤Î¥¢¥»¥¹¤ò¹Ô¤Ã¤Æ¤¤¤ë¡£
µ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Î¾ì¹ç¤Ë¤Ï¡¢ÄÁ¤·¤¤¥±¡¼¥¹¤Ç¤Ï¤¢¤ë¤¬¡¢Æä˻Ҷ¡¤¿¤Á¤ÎÃæ¤Ë¡¢IAE(¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹´ØϢǾ¾É)¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤ë¡£
¤³¤ÎǾ¾É¤Î´ðÁÃŪ¤Ê¥á¥«¥Ë¥º¥à¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤Þ¤À¡¢¤è¤¯¤ï¤«¤Ã¤Æ¤¤¤Ê¤¤¡£
IAE(¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹´ØϢǾ¾É)¤Ï¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¾õ¤Î¾É¾õ¤ò¼¨¤·¤¿¸å¡¢2-3Æü¤«¤é°ì½µ´Ö¤Î´Ö¤Ë¡¢¿À·ÐŪ¤ÊÃû¸õ¤ò¸½¤¹¡£
¾É¾õ¤È¤·¤Æ¤Ï¡¢Ç®¡¢¿À·Ð¾õÂÖ¤ÎÊѲ½¤¬°ìÈÌŪ¤Ç¤¢¤ê¡¢¤Þ¤¿¡¢È¯ºî¤¬¤·¤Ð¤·¤ÐÊó¹ð¤µ¤ì¤Æ¤¤¤ë¡£
¸Â¶ÉÀ­¿À·Ð¾É¾õ¤È¤·¤Æ¤Ï¡¢ÉÔÁ´Ëãáã¡¢±¿Æ°¾ã³²¡¢Ç¾¿À·ÐáÛÚ»¡¢¼º¸ì¾É¤Ê¤É¤¬¿ÊŸ¤¹¤ë¡£
Ǿ¿ñ±ÕºÙ˦Áý²Ã¤Î·çÇ¡¤ä¤¿¤ó¤Ñ¤¯¼Á¥ì¥Ù¥ë¤ÎÀµ¾ï¤Ç²º¤ä¤«¤Ê¾å¾º¤òȼ¤Ã¤Æ¤ª¤ë¤¿¤á¡¢Ç¾ÀÔ¿ñËì±ê¤Ï°ìÈÌŪ¤Ë¤Ï¡¢ÌÜΩ¤¿¤Ê¤¤¡£
IAE¤Ï¡¢¤·¤Ð¤·¤Ð¥¤¥ó¥Õ¥ë¥¨¥ó¥¶A·¿´¶À÷¤Ë¸«¤é¤ì¡¢Æäˡ¢H3N2·¿¥¦¥¤¥ë¥¹´¶À÷¤Ë¸«¤é¤ì¤ë¤¬¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶B·¿¤Ë¸«¤é¤ì¤ë¤³¤È¤âÊó¹ð¤µ¤ì¤Æ¤¤¤ë¡£
H1N1¤Ë¤Ä¤¤¤Æ¤â¡¢Æ±ÍͤξÉÎã¤È´ØÏ¢¤·¤Æ¤¤¤ë¤«¤É¤¦¤«¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤ï¤«¤é¤Ê¤¤¡£
ANE(µÞÀ­²õ»àÀ­Ç¾±ê)¤Ï¡¢¤³¤ì¤Þ¤Ç¡¢µ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤Ë¤Ä¤¤¤Æ¡¢½Ò¤Ù¤é¤ì¤Æ¤­¤¿¡£
ANE¤Ï¡¢·à¾É¤ÇñÁê¤Î·Ð²á¤ò¤¿¤É¤ë¤³¤È¤ËÆÃħ¤¬¤¢¤ë¡£
¤¹¤Ê¤ï¤Á¡¢¿À·Ð±ÇÁü¤«¤é¤Ï¡¢Æä˻뾲¤äǾ´´¤Ë¤ª¤±¤ë¿ȯÀ­Ç¾²õ»à¾ã³²¤¬¸«¤é¤ì¤ë¡£
¤½¤Î¤Û¤«¤Î¿À·ÐŪ¾É¾õ¤È¤·¤Æ¤Ï¡¢µÞÀ­±ê¾ÉÀ­Ã¦¿ñÀ­Â¿È¯¥Ë¥å¡¼¥í¥Ð¥Á¡¼(AIDP),µÞÀ­»µ¼ïÀ­Ç¾ÀÔ¿ñ±ê(ADEM)¡¢²£ÃÇÀÔ¿ñ±ê(TM)¡¢¾åÏÓÆ°Ì®¿À·Ð±ê¡¢¤Ê¤É¤¬µ¨ÀáÀ­¥¤¥ó¥Õ¥ë¥¨¥ó¥¶´ØÏ¢¤Ç¤Ï¸«¤é¤ì¤ë¤¬¡¢¾ÉÎã¤Ï¡¢¾¯¿ô¤Ç¤¢¤ë¡£


¸¶Ê¸

6. Are there immediate or delayed neurologic complications of H1N1 flu?

To date, no neurologic illnesses or events have been seen in the H1N1 cases. Ongoing surveillance is being conducted to assess these potential complications, however.

In the setting of seasonal influenza, rare cases of influenza-associated encephalopathy (IAE) have been reported, particularly among children. The underlying mechanism of the encephalopathy is not well understood. IAE is characterized by the occurrence of neurologic symptoms within a few days to a week following initial influenza-like illness; fever and altered mental status are common, and seizures are frequently reported. Focal neurologic signs, including paresis, movement disorders, cranial nerve palsies, and aphasia, may develop. CSF is generally unremarkable, with absence of pleocytosis and normal or mildly elevated protein levels.

IAE has been more frequently reported with influenza A, especially with A (H3N2) virus infection, but has been reported with influenza B. We do not know if the H1N1 strain might be associated with similar cases. Acute necrotizing encephalopathy (ANE), a particularly severe manifestation of para-infectious encephalopathy, has been described with seasonal influenza. ANE is characterized by a fulminant and monophasic course; multifocal necrotizing brain lesions predominant in the thalami and brainstem are seen on neuroimaging.

Case reports of other neurologic features, including acute demyelinating inflammatory neuropathy (AIDP), acute disseminated encephalomyelitis (ADEM) and transverse myelitis ™, as well as brachial neuritis have also been reported in the setting of seasonal influenza, although such reports are few.

Whether these neurologic features might be observed in the setting of H1N1 influenza infection is not known.

3.¡ÖInfluenza A virus-associated acute necrotizing encephalopathy in the United States¡×

4.¡Ö¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¡×

5.¡Ö¥¤¥ó¥Õ¥ë¥¨¥ó¥¶Ç¾¾É¥¬¥¤¥É¥é¥¤¥ó¡×

6.¡ÖH1N1 Can Cause Neurologic Complications in Children¡×

7.¡ÖInfluenza on the brain¡×

8.¡Ö°åÎŤγÎÊÝ¡¢¸¡±Ö¡¢³Ø¹»¡¦ÊÝ°é»ÜÀßÅù¤ÎÎ×»þµÙ¶È¤ÎÍ×ÀÁÅù¤Ë´Ø¤¹¤ë±¿ÍѻؿˡʲþÄêÈÇ¡Ë¡×Ê¿À®£²£±Ç¯£¶·î19Æü¸üÀ¸Ï«Æ¯¾Êȯɽ

¡¡

¤ªÃΤ餻:
ÆüËܤ«¤é¥·¥«¥´¤Î¥ª¥×¥·¥ç¥óÇäÇ㤬¤Ç¤­¤ë¤¿¤á¤Î¥Þ¥Ë¥å¥¢¥ë
¡Ö¥·¥«¥´¡¦¥ª¥×¥·¥ç¥óÇäÇãÀïά¥Þ¥Ë¥å¥¢¥ë¡×(A4ÈÇ273¥Ú¡¼¥¸¡¢5,900±ß)¤ò¤³¤Î¤¿¤Ó½ñ¤­¾å¤²¡¢È¯´©¤·¤Þ¤·¤¿¡£

ÆâÍÆ¡¦Ìܼ¡¤Î¤´³Îǧ¤ä¤ªµá¤á¤Ë¤Ä¤¤¤Æ¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£

¤ªÆÁÍѤʥÀ¥¦¥ó¥í¡¼¥ÉÈÇ-ÅŻҽñÀÒPDF¥Õ¥¡¥¤¥ë(273¥Ú¡¼¥¸¡¢3,980±ß)¤´´õ˾¤Î¾ì¹ç¤Ï¡¢¤³¤Á¤é¤ò¥¯¥ê¥Ã¥¯¤·¤Æ¤¯¤À¤µ¤¤¡£